地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：18372041646
传真：18771997407
邮箱：sales@amyjet.com
艾美捷科技特约代理Everest Biotech公司产品。
Everest Biotech公司成立于2000年，该公司主要生产山羊抗体，针对人类、小鼠、大鼠等物种的一系列重要的抗原。另外，Everest Biotech公司已通过ISO 9001:2015认证 (Certificate number CA14829)，可靠的质量和个性化的服务，使得客户以遍布全球。
所有来自Everest Biotech的抗体均有以下特性
（1） Everest Biotech自主研发生产
（2）全部经过肽亲和纯化以保证最佳的特异性和纯度；
（3）经过免疫原肽的ELISA和WB实验验证;
（4）PhD科学家团队，提供全方位技术支持服务。
Everest Biotech - Experts in antigen affinity purified goat polyclonal antibodies.
Since 2000, Everest has been producing a catalog containing thousands of goat antibodies against a broad range of human, mouse and rat proteins of biomedical interest.
Everest Biotech's commitment to quality and continuous improvement has been recognised with ISO 9001:2015 accreditation (Certificate number CA14829). The customers can be assured they will receive high quality product and excellent customer service.
按疾病种类分：
Allergy
Autoimmunity
Cancer
Cardiovascular
Genetic Disorders
Infectious
Metabolic
Neuronal
按生物功能分：
Adhesion
Apoptosis and its regulation
Autophagy
Cell Cycle and DNA Repair
Chromatin, Histone and RNA regulation
CNS and PNS
Cytoskeletal elements
Embryogenesis and cell differentiation
GAP, GBP, GEF. GRP, GTPase proteins
Inflammation
lectins
Lipids and Sterols Pathways
Mitochondrial proteins
Protein integrity, maturation and break down
Protein Kinases
Protein Phosphatases and Inhibitors
Receptors
SH2 domain containing proteins
SH3 domain containing proteins
Transcriptional regulators
Transcription factors
Translation and its regulation
Transporters, protein sorting, channels
<更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Everest Biotech"> Everest Biotech
<艾美捷科技代理Box scientific品牌全系列产品
BOX Scientific是一家专注于生命科学领域基于对流的解冻平台的生产商。自2010年在加利福尼亚圣何塞成立以来，BOX Scientific始终致力于程序化样品解冻技术，旨在保持样品完整性、控制过程变异性，并提高临床应用中的数据质量。公司由资深人士Derek Donohue领导，他在制药和基因组诊断领域拥有丰富经验。BOX Scientific的产品以其多功能性、大容量和高速解冻能力，树立了快速、安全和可重复的样品解冻新标准。公司产品包括工位一架解冻站（Station One）、直升机场机架解冻站（Heliport）。
▍BOX Scientific公司产品线
●工位一架解冻站（Station One）
仅使用环境空气即可在极短的时间内解冻冷冻试剂和样品。固定平台设计，实现高通量样品解冻，满足精细样品和试剂的解冻需求。样品和试剂的解冻过程可重复、可程序化，且安全可靠。应用场景：
※适用于需要快速解冻且保持样品完整性的实验室环境。
※特别适用于临床研究和生物样本库管理，确保样品在解冻过程中的稳定性和一致性。
● 直升机场机架解冻站（Heliport）
采用与Station One相同的对流原理，是市场上最大的样品解冻系统。具备自动化集成功能，是首款实现自动化集成的解冻系统。强大的对流系统能将解冻时间缩短多达75%，同时允许解冻后的样品直接无缝过渡到后续自动化流程中。应用场景：
※适用于大规模样品解冻需求，如生物样本库、临床研究机构等。
※特别适用于需要高度自动化和高效解冻的实验室环境，提升整体工作流程的效率和准确性。
▍Box scientific产品列表
<| 货号 | 品名 |
| 1-300-0725 | Station One Rack Thawing Station |
| 1-300-70000 | The Heliport Thawing Station |
艾美捷科技代理Pel-Freez 品牌。
在20世纪50年代，为了响应生物医学研究人员对材料的大量需求，Pel-Freez公司扩展到动物生物制品领域，并从那时起一直为生物医学界服务。在过去的几十年里，Pel-Freez进一步扩大了其产品范围。Pel-Freez提供包括各种动物组织、提取物和血液制品以及关键的人类生物制品。这些产品广泛应用于体外诊断试剂盒开发、药物发现、疫苗评估、HLA分型等领域。
Pel-Freez产品包括：
（1）冻干组织粉：提供多种动物组织的冻干粉，便于储存和使用，适用于各种生物化学和分子生物学实验。
（2）血清产品：包括正常兔血清和其他物种的血清产品，如人血清、人血浆等，用于细胞培养和生物医学研究。
（3）血浆和血液补体：提供人血浆和血液补体产品，用于免疫学研究和补体系统的功能分析。
（4）组织和抗体：提供多种组织的提取物和特异性抗体，支持基础研究和诊断开发。
Pel-Freez拥有专有的分离技术，能够去除超过96%的背景LGG和LGM抗体，同时保持补充功能。此外，其所有产品都经过高度标准化的生产过程，确保质量稳定可靠。Pel-Freez在疫苗开发用途兔补体方面是行业领导者，其热销产品涵盖人补体、成年（幼）兔补体、豚鼠补体等各类。Pel-Freez的客户群体包括全球的科研机构、制药公司、生物技术公司和临床诊断实验室，以及疫苗研究与开发领域的专家。Pel-Freez通过ISO 9001认证，确保其产品的质量和一致性。此外，其工厂和农场也遵循严格的伦理和人道动物实践标准。
艾美捷科技代理HaemoScan 品牌。
HaemoScan专注于血液相容性测试和生物标志物分析，致力于为血液接触医疗设备和新候选药物提供临床前体外测试服务，帮助研究者更深入地了解产品或获得批准将其产品快速推向市场。除了提供专业的测试服务外，HaemoScan还销售基于内部开发方法的测试试剂盒。
检测产品包括：
（1）血液相容性测试：HaemoScan在医用管和医用流体袋的血液相容性测试方面具有丰富经验。这些测试有助于了解聚合物、添加剂和化合物对血液的影响，以及选择和塑料选择对产品设计的影响。
（2）生物标志物分析：HaemoScan提供生物标志物检测试剂盒，用于评估血液和生物材料之间的相互作用以及先天免疫活性（如补体活性）。
（3）测试试剂盒：HaemoScan的实验室方法已经转换为即用型检测试剂盒，这些试剂盒主要用于评估血液和生物材料之间的相互作用，以及测量血浆中经典和替代途径的补体活性。
<<<< " data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理HaemoScan品牌"> 艾美捷科技代理HaemoScan品牌
<艾美捷科技有限公司代理Echelon Biosciences的产品：
http://www.amyjet.com/Index/lists/catid/27/kid/57.html
Echelon Biosciences成立于1997年，致力于为脂质研究领域提供高品质的检测方法和检测试剂。
Echelon Biosciences Incorporated (EBI) was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. Initially, EBI was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, with the aim to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.
Echelon Bioscience的产品和服务包括：
| (2S)-Oleyl LPA (Echelon Bioscience, CAT#L-0186) |
| (E,E,E)-Geranylgeraniol (Echelon Bioscience, CAT#S-0200) |
| (E,E)-Farnesoic acid (Echelon Bioscience, CAT#S-0151) |
| (E,E)-Methyl Farnesoate (Echelon Bioscience, CAT#S-0153) |
| (S,S) Bisoleoyl-lysobisphosphatidic acid (LBPA) (Echelon Bioscience, CAT#L-B181) |
| (S)-FTY720 Phosphate (Echelon Bioscience, CAT#B-0721) |
| [4-(Decanoylamino)benzyl]phosphonic acid (GWJ-23, GWJ-A-23) (Echelon Bioscience, CAT#L-3223) |
| [D-Ala2]-Deltorphin II (Echelon Bioscience, CAT#275-21) |
| [Hyp3]-Bradykinin (Echelon Bioscience, CAT#191-65) |
| [Ser25] Protein Kinase C Substrate (19-31) (Echelon Bioscience, CAT#871-21) |
| 1-Deoxy-D-xylulose (DX) (Echelon Bioscience, CAT#I-M050A) |
| 1-Deoxy-D-xylulose 5-phosphate (DXP) (Echelon Bioscience, CAT#I-M050) |
| 1-Hydroxy-2-methyl-2-buten-4-yl 4-diphosphate (HDMAPP) (Echelon Bioscience, CAT#I-M055) |
| 1-Methylhistamine dihydrochloride (Echelon Bioscience, CAT#B-0032) |
| 1-Naphthalenesulfonyl-Ile-Trp-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-76) |
| 1-Stearoyl-2-Arachidonoyl-sn-Glycerol (Echelon Bioscience, CAT#L-0024) |
| 1,2-Distearoyl-sn-glycerol (Echelon Bioscience, CAT#L-0018) |
| 1,3-DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2216) |
| 1,3-POPE (16:0/18:1 PE) (Echelon Bioscience, CAT#L-2368) |
| 16:0 LPE (Echelon Bioscience, CAT#L-2516) |
| 16:0 LPG (Echelon Bioscience, CAT#L-5216) |
| 16:0 LPThr (Echelon Bioscience, CAT#L-3316) |
| 18:1 LysoPEth (Echelon Bioscience, CAT#L-6030) |
| 18:2 LysoPC (Echelon Bioscience, CAT#L-1520) |
| 1D-O-(1,2-Di-O-oleoyl-sn-(2S)-glycerol-3-phospho)-3-(phosphothionate)-myo-inositol (Echelon Bioscience, CAT#P-3S18) |
| 1R,2R-B13 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0042) |
| 2-Acetyl-5-tetrahydroxybutyl imidazole (THI) (Echelon Bioscience, CAT#B-0031) |
| 2-C-Methyl-D-erythritol 2,4-cyclophosphate (Echelon Bioscience, CAT#I-M054) |
| 2-C-Methyl-D-erythritol 4-phosphate (MEP) (Echelon Bioscience, CAT#I-M051) |
| 2-C-Methyl-erythritol (ME) (Echelon Bioscience, CAT#I-M051A) |
| 2-Furoyl-LIGR-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-12) |
| 2-Furoyl-LIGRL-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-11) |
| 2-Furoyl-LIGRLO-NH2 (Potent and Selective Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-10) |
| 2-O-Butyryl-Ins(1,3,4,5,6)P5/PM (Echelon Bioscience, CAT#Q-M1396) |
| 2,3-Oxidosqualene (racemic) (Echelon Bioscience, CAT#S-0301) |
| 2,3,22,23-Dioxidosqualene (Echelon Bioscience, CAT#S-0302) |
| 2,3,5-Tri-O-butyryl-Ins(1,4,6)P3/AM (Echelon Bioscience, CAT#Q-M0146) |
| 2S-OMPT (Echelon Bioscience, CAT#L-9418) |
| 2Z,6Z-Farnesol (Echelon Bioscience, CAT#S-0170) |
| 2Z,6Z-Farnesyl Diphosphate (Echelon Bioscience, CAT#I-0170) |
| 3-a-Aminocholestane (3AC, SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0341) |
| 3,3′-Bisoleoyl-LBPA tetrabutylammonium salt (Echelon Bioscience, CAT#L-B182) |
| 3C-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3C916) |
| 3C-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3C908) |
| 3S-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3S916) |
| 3S-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3S908) |
| 4-Demethylaminosancycline (CMT-3) (Echelon Bioscience, CAT#B-0802) |
| 4-Diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) (Echelon Bioscience, CAT#I-M052) |
| 4-Methylumbelliferone (Echelon Bioscience, CAT#JK201388) |
| 5-Ketoclomazone (DXP Synthase Inhibitor) (Echelon Bioscience, CAT#B-4101) |
| 5′ PtdIns(3,4,5)P3 Phosphatase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1400) |
| 6-O-palmitoyl-L-ascorbic acid (HAse Inhibitor) (Echelon Bioscience, CAT#B-0601) |
| 7-azido-4-methylcoumarin (AzMC, Hydrogen sulfide detector) (Echelon Bioscience, CAT#D-0010) |
| 9-tert-Butyl Doxycycline HCl (Echelon Bioscience, CAT#B-0801) |
| 9(10)-Nitrooleic Acid (Echelon Bioscience, CAT#L-0112) |
| 9Z-Octadecenyl phosphate (Echelon Bioscience, CAT#L-0418) |
| a-Secretase Substrate (Echelon Bioscience, CAT#640-55) |
| ABC294640 (SPHK2 Inhibitor) (Echelon Bioscience, CAT#B-0025) |
| Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide (Metalloendopeptidase Substrate) (Echelon Bioscience, CAT#855-46) |
| Ac-Ala-Arg-AMC (Echelon Bioscience, CAT#877-13) |
| Ac-Ala-Glu-Val-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-65) |
| Ac-Ala-Glu-Val-Asp-CHO (Caspase 3 Inhibitor) (Echelon Bioscience, CAT#864-65) |
| Ac-Ala-Glu-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-65) |
| Ac-Arg-Ala-Arg-AMC (Echelon Bioscience, CAT#855-71) |
| Ac-Arg-Ala-Val-AMC (Echelon Bioscience, CAT#877-08) |
| Ac-Arg-Gly-Phe-Phe-Pro-AFC (Cathepsin D Substrate, fluorogenic) (Echelon Bioscience, CAT#874-19) |
| Ac-Arg-Gly-Phe-Phe-Pro-AMC (Echelon Bioscience, CAT#877-06) |
| Ac-Arg-Leu-Arg-AMC (Echelon Bioscience, CAT#920-75) |
| Ac-Arg-Ser-Leu-Lys-AMC (Site 1 Protease Substrate, fluorogenic) (Echelon Bioscience, CAT#877-09) |
| Ac-Asp-Gln-Met-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-26) |
| Ac-Asp-Gln-Met-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-22) |
| Ac-Asp-Glu-Val-Asp-4MbNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#861-18) |
| Ac-Asp-Glu-Val-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-18) |
| Ac-Asp-Glu-Val-Asp-pNA (Caspase-3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-20) |
| Ac-Asp-Met-Gln-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-30) |
| Ac-Asp-Met-Gln-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-28) |
| Ac-Asp-Met-Gln-Asp-pNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-25) |
| Ac-DEVD-AFC, (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-17) |
| Ac-DEVD-CHO, Caspase 3 (Apopain) Inhibitor (Echelon Bioscience, CAT#864-20) |
| Ac-Glu-Ser-Met-Asp-AFC (Procaspase 3 Substrate, fluorogenic) (Echelon Bioscience, CAT#880-22) |
| Ac-Glu-Ser-Met-Asp-CHO (Procaspase 3 Inhibitor) (Echelon Bioscience, CAT#864-22) |
| Ac-Glu-Val-Asn-Leu-AMC (Echelon Bioscience, CAT#877-11) |
| Ac-Glu-Val-Asn-Leu-pNA (Echelon Bioscience, CAT#876-06) |
| Ac-Ile-Gln-Ala-Cys-Arg-Gly-OH (Caspase Active Site Peptide) (Echelon Bioscience, CAT#866-12) |
| Ac-Ile-Glu-Pro-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-30) |
| Ac-Ile-Glu-Pro-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-69) |
| Ac-Ile-Glu-Pro-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#865-30) |
| Ac-Ile-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-58) |
| Ac-Ile-Glu-Thr-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-58) |
| Ac-Ile-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor / Granzyme B Inhibitor II) (Echelon Bioscience, CAT#860-59) |
| Ac-Ile-Glu-Thr-Asp-pNA (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-56) |
| Ac-Leu-Asp-Glu-Ser-Asp-AMC (Caspase 2/3 Substrate) (Echelon Bioscience, CAT#860-43) |
| Ac-Leu-Glu-Glu-Asp-AFC (Caspase 13 Substrate) (Echelon Bioscience, CAT#863-55) |
| Ac-Leu-Glu-Glu-Asp-AMC (Caspase 13 Substrate) (Echelon Bioscience, CAT#862-55) |
| Ac-Leu-Glu-Glu-Asp-CHO (Caspase 13 Inhibitor) (Echelon Bioscience, CAT#864-85) |
| Ac-Leu-Glu-Glu-Asp-pNA (Caspase 13 Substrate) (Echelon Bioscience, CAT#861-85) |
| Ac-Leu-Glu-His-Asp-AFC (Caspase 9 Substrate) (Echelon Bioscience, CAT#863-40) |
| Ac-Leu-Glu-His-Asp-AMC (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-45) |
| Ac-Leu-Glu-His-Asp-CHO (Caspase 9 Inhibitor) (Echelon Bioscience, CAT#864-45) |
| Ac-Leu-Glu-His-Asp-pNA (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-47) |
| Ac-Leu-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-44) |
| Ac-Leu-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor) (Echelon Bioscience, CAT#864-44) |
| Ac-Leu-Glu-Val-Asp-AFC (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#863-42) |
| Ac-Leu-Glu-Val-Asp-AMC (Caspase 4 Substrate) (Echelon Bioscience, CAT#860-49) |
| Ac-Leu-Glu-Val-Asp-CHO (Caspase 4 (ICH-2) Inhibitor) (Echelon Bioscience, CAT#864-42) |
| Ac-Leu-Glu-Val-Asp-pNA (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#860-42) |
| Ac-Leu-Leu-Arg-AMC (Echelon Bioscience, CAT#877-12) |
| Ac-Leu-Leu-Tyr-AFC (Echelon Bioscience, CAT#875-20) |
| Ac-Leu-Val-Lys-CHO (Cathepsin B Inhibitor II) (Echelon Bioscience, CAT#866-39) |
| Ac-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphthylamide (Echelon Bioscience, CAT#878-02) |
| Ac-Lys-Pro-Arg-AMC (Echelon Bioscience, CAT#877-07) |
| Ac-Orn-Phe-Arg-AMC (Tryptase Substrate, fluorogenic) (Echelon Bioscience, CAT#871-94) |
| Ac-Phe-Ser-Arg-pNA (Echelon Bioscience, CAT#876-01) |
| Ac-Thr-Gln-Thr-Asp-AFC (DRONC Substrate) (Echelon Bioscience, CAT#850-16) |
| Ac-Thr-Gln-Thr-Glu-AFC (DRONC Substrate I) (Echelon Bioscience, CAT#850-17) |
| Ac-Trp-Glu-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-61) |
| Ac-Trp-Glu-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-63) |
| Ac-Trp-Glu-His-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#863-63) |
| Ac-Trp-Glu-His-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-60) |
| Ac-Trp-Glu-His-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-66) |
| Ac-Trp-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-64) |
| Ac-Trp-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-66) |
| Ac-Tyr-Glu-Val-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-41) |
| Ac-Tyr-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-17) |
| Ac-Tyr-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-16) |
| Ac-Tyr-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-15) |
| Ac-Val-Ala-Asp-4MbNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#863-12) |
| Ac-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-12) |
| Ac-Val-Ala-Asp-CHO (Caspase 1 (ICE) Inhibitor) (Echelon Bioscience, CAT#864-12) |
| Ac-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-11) |
| Ac-Val-Asn-Leu-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-70) |
| Ac-Val-Asp-Gln-Gln-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-44) |
| Ac-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-48) |
| Ac-Val-Asp-Val-Ala-Asp-AMC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-48) |
| Ac-Val-Asp-Val-Ala-Asp-CHO (Caspase 2 (ICH-1) Inhibitor) (Echelon Bioscience, CAT#864-46) |
| Ac-Val-Asp-Val-Ala-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-46) |
| Ac-Val-Gln-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-54) |
| Ac-Val-Glu-His-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-74) |
| Ac-Val-Glu-Ile-Asp-AMC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-52) |
| Ac-Val-Glu-Ile-Asp-CHO (Caspase 6 (Mch2) Inhibitor) (Echelon Bioscience, CAT#860-57) |
| Ac-Val-Glu-Ile-Asp-pNA (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-50) |
| Ac-Val-Glu-Thr-Asp-AMC (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-26) |
| Ac-Val-Lys-Met-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-72) |
| Ac-VEID-AFC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#863-52) |
| Ac-YVAD-CHO, Caspase 1 (ICE) Inhibitor (Echelon Bioscience, CAT#864-15) |
| Acetyl Calcitonin, salmon (Echelon Bioscience, CAT#237-36) |
| Acetyl-Beta Amyloid (25-35) (Echelon Bioscience, CAT#641-59) |
| Acetyl-Neurotensin (8-13) (Echelon Bioscience, CAT#631-41) |
| Acid Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-3200) |
| ACTH (1-17), human (Echelon Bioscience, CAT#111-75) |
| ACTH (1-24), human (Echelon Bioscience, CAT#111-36) |
| ACTH (1-39), rat (Echelon Bioscience, CAT#115-10) |
| ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38), human (Echelon Bioscience, CAT#111-45) |
| Activity Dependant Neuroprotective Protein (74-81) (mouse, rat) (Echelon Bioscience, CAT#878-03) |
| ADAM substrate (Echelon Bioscience, CAT#825-15) |
| Adamantaneacetyl-Bradykinin [DArg0,Hyp3,Thi5,8,DPhe7] (Echelon Bioscience, CAT#191-84) |
| Adrenal Secretogranin, bovine (Echelon Bioscience, CAT#313-20) |
| Adrenomedullin (1-50), rat (Echelon Bioscience, CAT#335-75) |
| Adrenomedullin (1-52), human (Echelon Bioscience, CAT#331-80) |
| Adrenomedullin (11-50), rat (Echelon Bioscience, CAT#335-80) |
| Adrenomedullin (22-52), human (Echelon Bioscience, CAT#331-82) |
| Agatoxin IVa ( SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 (Echelon Bioscience, CAT#429-15) |
| Akt Substrate (Echelon Bioscience, CAT#868-15) |
| Alkyl-OMPT (Echelon Bioscience, CAT#L-9518) |
| Allatostatin B2, cockroach (Echelon Bioscience, CAT#781-20) |
| Alpha MSH [D-Phe7] (Echelon Bioscience, CAT#570-42) |
| Alpha MSH [Nle4,D-Phe7] (Echelon Bioscience, CAT#570-43) |
| Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10](4-10) amide (Echelon Bioscience, CAT#571-49) |
| AMARA peptide substrate (Echelon Bioscience, CAT#890-23) |
| Aminocardiolipin (Amino-CL) (Echelon Bioscience, CAT#L-C16A) |
| Amylin (1-37), human, amide (Echelon Bioscience, CAT#641-50) |
| Amyloid Blocker (Echelon Bioscience, CAT#641-81) |
| Amyloid Fragment (Pro18,Asp21) (17-21) (Echelon Bioscience, CAT#641-64) |
| Angiotensin (1-5) (Echelon Bioscience, CAT#131-53) |
| Angiotensin (1-7) (Echelon Bioscience, CAT#131-41) |
| Angiotensin I (1-9), DRVYIHPFH-OH (Echelon Bioscience, CAT#131-55) |
| Angiotensin I (human) (Echelon Bioscience, CAT#131-25) |
| Angiotensin I [Asn1,Val5,Asn9], salmon (Echelon Bioscience, CAT#137-40) |
| Angiotensin I [Asn1,Val5], goosefish (Echelon Bioscience, CAT#137-39) |
| Angiotensin I [Val5,Asn9], bullfrog (Echelon Bioscience, CAT#137-36) |
| Angiotensin II Antipeptide (Echelon Bioscience, CAT#131-64) |
| Angiotensin II-[Sar1] (Echelon Bioscience, CAT#131-65) |
| Angiotensin II, human (Echelon Bioscience, CAT#131-49) |
| Angiotensin III, human / Angiotensin II-[Des Asp1] (Echelon Bioscience, CAT#131-76) |
| Angiotensinogen (1-14) Renin Substrate, porcine (Echelon Bioscience, CAT#131-82) |
| Anti human Vps34 Antibody (Echelon Bioscience, CAT#Z-R016) |
| Anti-hVps34 Antibody for IP (Echelon Bioscience, CAT#Z-R015) |
| Anti-PEth Autologous IgG ELISA (Echelon Bioscience, CAT#K-5000A) |
| Anti-PtdIns(3,4,5)P3 IgM HRP (Echelon Bioscience, CAT#Z-H345) |
| Anti-PtdIns(3,4,5)P3 IgM In Ascities (Echelon Bioscience, CAT#Z-A345) |
| Anti-PtdIns(4,5)P2 IgM In Ascites (Echelon Bioscience, CAT#Z-A045) |
| Anti-Rat F1-ATP Synthase Alpha Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPA) |
| Anti-Rat F1-ATP Synthase Beta Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPB) |
| Antibody Sample Pack (Echelon Bioscience, CAT#Z-P100) |
| AP-811 (NPR-C receptor ligand) (Echelon Bioscience, CAT#492-10) |
| Apamin, bee venom (SS1-11, SS3-15) (Echelon Bioscience, CAT#425-10) |
| APP Beta Secretase Inhibitor (Echelon Bioscience, CAT#649-10) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-22) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-23) |
| Arachidonoyl LPA, 20:4 LPA (Echelon Bioscience, CAT#L-0204) |
| Arachidoyl LPA, 20:0 LPA (Echelon Bioscience, CAT#L-0200) |
| Arg-Gly-Asp-Ser (RGDS) (Echelon Bioscience, CAT#450-29) |
| ARN14988 (aCDase Inhibitor) (Echelon Bioscience, CAT#B-0041) |
| AS1938909 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0343) |
| AS1949490 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0342) |
| AS604850 (PI3-K gamma Inhibitor 2) (Echelon Bioscience, CAT#B-0302) |
| AS605240 (PI3-K gamma Inhibitor 1) (Echelon Bioscience, CAT#B-0301) |
| Atrial Natriuretic Peptide (1-28), human / ANP (1-28), human (Echelon Bioscience, CAT#151-25) |
| Atrial Natriuretic Peptide (1-28), rat (Echelon Bioscience, CAT#155-56) |
| Atrial Natriuretic Peptide (4-28), rat / Auriculin B (Echelon Bioscience, CAT#155-62) |
| Atrial Natriuretic Peptide (ANP) (4-24), frog (Echelon Bioscience, CAT#153-15) |
| Atrial Natriuretic Peptide (ANP) Des[18-22] (4-23) amide, rat (Echelon Bioscience, CAT#155-40) |
| Atriopeptin III, rat [ANP (127-150), rat] (Echelon Bioscience, CAT#155-63) |
| ATX Sandwich ELISA Assay Service (Echelon Bioscience, CAT#T-5600) |
| ATX-Red AR-2 (Echelon Bioscience, CAT#L-2010) |
| Autocamptide-2 Related Inhibitoy Peptide (Echelon Bioscience, CAT#891-24) |
| Autocamtide-2 Related Inhibitory Peptide, myristoylated (Echelon Bioscience, CAT#891-26) |
| Autotaxin Activity Assay (Echelon Bioscience, CAT#K-4100) |
| Autotaxin Activity Assay Service (Echelon Bioscience, CAT#T-4100) |
| Autotaxin Enzyme, active (Echelon Bioscience, CAT#E-4000) |
| Autotaxin Inhibitor Screening Assay Service (Echelon Bioscience, CAT#T-4200) |
| Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200) |
| Autotaxin Sandwich ELISA Kit (Echelon Bioscience, CAT#K-5600) |
| BAM (6-22) Bovine Adrenal Medulla Peptide (6-22) (Echelon Bioscience, CAT#313-64) |
| BAM 3200 Bovine Adrenal Medulla Peptide E (Echelon Bioscience, CAT#313-65) |
| Benzo[a]pyrene (Echelon Bioscience, CAT#B-0050) |
| Beta Amyloid (25-35), human (Echelon Bioscience, CAT#641-40) |
| Beta Amyloid [Glu11] (10-16), human (Echelon Bioscience, CAT#641-45) |
| Beta Amyloid [Nle35] (1-40), human (Echelon Bioscience, CAT#641-13) |
| Beta Amyloid (1-16) [Gln11], human (Echelon Bioscience, CAT#641-35) |
| Beta Amyloid (1-16), rat (Echelon Bioscience, CAT#642-36) |
| Beta Amyloid (1-28), [Gln11], human (Echelon Bioscience, CAT#641-17) |
| Beta Amyloid (1-28), rat (Echelon Bioscience, CAT#642-18) |
| Beta Amyloid (1-40), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-14) |
| Beta Amyloid (1-40), rat (Echelon Bioscience, CAT#642-10) |
| Beta Amyloid (1-42), human (Echelon Bioscience, CAT#641-15) |
| Beta Amyloid (1-42), human – HFIP (Echelon Bioscience, CAT#641-00) |
| Beta Amyloid (1-42), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-22) |
| Beta Amyloid (1-42), rat (Echelon Bioscience, CAT#642-15) |
| Beta Amyloid (10-20), human (Echelon Bioscience, CAT#641-21) |
| Beta Amyloid (12-28), human (Echelon Bioscience, CAT#641-19) |
| Beta Amyloid (13-16), human (Echelon Bioscience, CAT#641-88) |
| Beta Amyloid (16-10), reverse, human (Echelon Bioscience, CAT#641-54) |
| Beta Amyloid (17-42), human (Echelon Bioscience, CAT#641-90) |
| Beta Amyloid (22-35), human (Echelon Bioscience, CAT#641-44) |
| Beta Amyloid (25-35) [Ala28] (Echelon Bioscience, CAT#640-19) |
| Beta Amyloid (25-35) [Gly35] (Echelon Bioscience, CAT#640-21) |
| Beta Amyloid (25-35) [Nle35], human (Echelon Bioscience, CAT#641-53) |
| Beta Amyloid (26-35), human (Echelon Bioscience, CAT#641-41) |
| Beta Amyloid (27-35), human (Echelon Bioscience, CAT#641-42) |
| Beta Amyloid (28-35), human (Echelon Bioscience, CAT#641-43) |
| Beta Amyloid (35-25), reverse, human (Echelon Bioscience, CAT#641-47) |
| Beta Amyloid (40-1), reverse, human (Echelon Bioscience, CAT#641-70) |
| Beta Amyloid (42-1) reverse, human (Echelon Bioscience, CAT#641-69) |
| Beta Amyloid [Gln 22] (1-40), human (Echelon Bioscience, CAT#640-20) |
| Beta Amyloid [Gln 22] (1-42), human (Echelon Bioscience, CAT#642-30) |
| Beta Amyloid [Gln11] (1-40) , human (Echelon Bioscience, CAT#641-11) |
| Beta Amyloid [Glp3] (3-42), human (Echelon Bioscience, CAT#641-16) |
| Beta Amyloid [Glu11] (1-16) (Echelon Bioscience, CAT#641-36) |
| Beta Amyloid [Glu11] (1-38), human (Echelon Bioscience, CAT#641-25) |
| Beta Amyloid [Glu11] (1-40), human (Echelon Bioscience, CAT#641-10) |
| Beta Amyloid [Glu11] (1-40), human – HFIP (Echelon Bioscience, CAT#641-01) |
| Beta Amyloid [Glu11], (1-28), human (Echelon Bioscience, CAT#641-18) |
| Beta Endorphin, human / Beta Lipotropin (61-91), human (Echelon Bioscience, CAT#291-25) |
| Beta MSH, human (Echelon Bioscience, CAT#571-47) |
| Beta Secretase Inhibitor II (Echelon Bioscience, CAT#649-18) |
| Big Endothelin (1-38), human (Echelon Bioscience, CAT#331-30) |
| Big Endothelin (1-39), porcine (Echelon Bioscience, CAT#334-10) |
| Big Endothelin (1-39), rat (Echelon Bioscience, CAT#335-50) |
| Big Endothelin 1 [D-Val22] (16-38), human (Echelon Bioscience, CAT#331-32) |
| Big Endothelin 2 (1-37), human (Echelon Bioscience, CAT#331-40) |
| Big Gastrin, sulfated (Echelon Bioscience, CAT#471-80) |
| Bilirubin (Echelon Bioscience, CAT#F-H120) |
| Bilirubin Conjugate (Echelon Bioscience, CAT#F-H130) |
| Bilirubin dimethyl ester (Echelon Bioscience, CAT#F-H110) |
| Biliverdin Hydrochloride (Echelon Bioscience, CAT#F-H100) |
| Biotin 18:0 LysoPC (Echelon Bioscience, CAT#L-15B18) |
| Biotin Monolysocardiolipin (Echelon Bioscience, CAT#L-M16B) |
| Biotin Phosphatidylinositol (Echelon Bioscience, CAT#C-00B6) |
| Biotin Phosphatidylinositol 3-phosphate (Echelon Bioscience, CAT#C-03B6) |
| Biotin Phosphatidylinositol 3,4-bisphosphate (Echelon Bioscience, CAT#C-34B6) |
| Biotin Phosphatidylinositol 3,5-bisphosphate (Echelon Bioscience, CAT#C-35B6) |
| Biotin Phosphatidylinositol 4-phosphate (Echelon Bioscience, CAT#C-04B6) |
| Biotin Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45B6) |
| Biotin Phosphatidylinositol 5-phosphate (Echelon Bioscience, CAT#C-05B6) |
| Biotin PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6) |
| Biotin Sphingomyelin (Echelon Bioscience, CAT#S-400B) |
| biotin-C12-ether LBPA (Echelon Bioscience, CAT#L-B1B12) |
| Biotin-Cardiolipin (Echelon Bioscience, CAT#L-C16B) |
| Biotin-Ceramide (Echelon Bioscience, CAT#S-300B) |
| Biotin-Lactosylceramide (Echelon Bioscience, CAT#S-600B) |
| Biotin-monolysocardiolipin (Echelon Bioscience, CAT#L-MB16) |
| Biotin-Phosphatidic Acid (Echelon Bioscience, CAT#L-41B16) |
| Biotin-Phosphatidylcholine (Echelon Bioscience, CAT#L-11B16) |
| Biotin-Phosphatidylethanol (12:0/18:1) (Echelon Bioscience, CAT#L-60B18) |
| Biotin-Phosphatidylethanol (6:0/16:0) (Echelon Bioscience, CAT#L-60B16) |
| Biotin-Phosphatidylethanolamine (Echelon Bioscience, CAT#L-21B6) |
| Biotin-Phosphatidylglycerol (Echelon Bioscience, CAT#L-51B16) |
| Biotin-Phosphatidylserine (Echelon Bioscience, CAT#L-31B16) |
| Biotinyl-alpha MSH [Nle4,DPhe7] (Echelon Bioscience, CAT#570-46) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-B345B) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-B345) |
| Biotinylated Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-B034) |
| Biotinylated Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-B045) |
| Biotinylated Select-HA 1000k (Echelon Bioscience, CAT#HYA-B1000-200) |
| Biotinylated Select-HA 250k (Echelon Bioscience, CAT#HYA-B250-200) |
| Biotinylated Select-HA 500k (Echelon Bioscience, CAT#HYA-B500-200) |
| Biotinylated Select-HA 50k (Echelon Bioscience, CAT#HYA-B50-200) |
| Biotinylated Versican G1 Domain (Echelon Bioscience, CAT#G-HA02) |
| Bisepoxy Juvenile Hormone III (Echelon Bioscience, CAT#S-0157) |
| BOC-Lys(Ac)-AMC (Histone Deacetylase (HDAC) Substrate) (Echelon Bioscience, CAT#888-20) |
| Boc-Val-Gly-Arg-bNA (Plasminogen Activator Substrate) (Echelon Bioscience, CAT#875-17) |
| BOC-Val-Pro-Arg-AFC (Thrombin substrate, fluorogenic) (Echelon Bioscience, CAT#885-11) |
| BODIPY FL Phosphatidylinositol (Echelon Bioscience, CAT#C-00F6) |
| BODIPY FL Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45F6) |
| BODIPY FL PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6) |
| BODIPY FL PI(3,4)P2 (Echelon Bioscience, CAT#C-34F6) |
| BODIPY FL PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6) |
| BODIPY FL PI(3)P (Echelon Bioscience, CAT#C-03F6) |
| BODIPY FL PI(4)P (Echelon Bioscience, CAT#C-04F6) |
| BODIPY FL PI(5)P (Echelon Bioscience, CAT#C-05F6) |
| Bodipy Labeled PIP Sample Pack (Echelon Bioscience, CAT#C-99F6) |
| BODIPY TMR Phosphatidylinositol (Echelon Bioscience, CAT#C-00M6) |
| BODIPY TMR PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6) |
| BODIPY TMR PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6) |
| BODIPY TMR PI(3,5)P2 (Echelon Bioscience, CAT#C-35M6) |
| BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6) |
| BODIPY TMR PI(4,5)P2 (Echelon Bioscience, CAT#C-45M6) |
| BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6) |
| BODIPY TMR PI(5)P (Echelon Bioscience, CAT#C-05M6) |
| BODIPY-FL PEth (Echelon Bioscience, CAT#L-60F18) |
| Bombesin (Echelon Bioscience, CAT#177-25) |
| Bovine Adrenal Medulla Docosapeptide / BAM 22P (Echelon Bioscience, CAT#313-45) |
| Bovine Thrombin (Echelon Bioscience, CAT#E-9000) |
| Bradykinin (1-7) (Echelon Bioscience, CAT#191-72) |
| Bradykinin (1-9) (Echelon Bioscience, CAT#191-25) |
| Bradykinin B2 Antagonist (HOE 140) (Echelon Bioscience, CAT#191-85) |
| Bradykinin Ile-Ser, (T-Kinin) (Echelon Bioscience, CAT#191-49) |
| Bradykinin Potentiating Factor (Angiotensin Converting Enzyme Inhibitor) (Echelon Bioscience, CAT#131-95) |
| Brain Derived Acidic Fibroblast Growth Factor (1-11), bovine (Echelon Bioscience, CAT#510-42) |
| Brain Natriuretic Peptide (BNP) (1-32), human / Brain ANP (1-32), human (Echelon Bioscience, CAT#152-52) |
| BrP-LPA (Echelon Bioscience, CAT#L-7416) |
| C-Peptide [Tyr0] / Proinsulin (32-63) Tyr0 (Echelon Bioscience, CAT#211-27) |
| C-Type Natriuretic Peptide (CNP) (1-22), human (Echelon Bioscience, CAT#151-60) |
| C6NIB (H2O2 vapor sensor) (Echelon Bioscience, CAT#D-0020) |
| Caerulein (ceruletide) (Echelon Bioscience, CAT#471-65) |
| Calcitonin Gene Related Peptide (CGRP), human (Echelon Bioscience, CAT#231-27) |
| Calcitonin Gene Related Peptide I (8-37), human / CGRP Receptor Antagonist (Echelon Bioscience, CAT#231-31) |
| Calcitonin Gene Related Peptide II (8-37), human / Beta CGRP (Echelon Bioscience, CAT#231-22) |
| Calcitonin Gene Related Peptide II (CGRP II, human), cyclic (Echelon Bioscience, CAT#231-29) |
| Calcitonin, human, cyclic (Echelon Bioscience, CAT#231-25) |
| Calcitonin, salmon (Echelon Bioscience, CAT#237-26) |
| Calcitonin, salmon [Des-Cys1] (Echelon Bioscience, CAT#237-34) |
| Calcitonin, salmon [Des-Tyr22] (Echelon Bioscience, CAT#237-32) |
| Calmodulin Binding Domain Ca2+/Calmodulin Dependent Protein (Echelon Bioscience, CAT#740-60) |
| Calmodulin Dependent Protein Kinase Substrate (Echelon Bioscience, CAT#890-81) |
| Calmodulin Kinase II Inhibitor (281-309) (Echelon Bioscience, CAT#893-40) |
| Calpastatin Peptide (Ac 184-210 ) (Echelon Bioscience, CAT#870-20) |
| cAMP Dependent Protein Kinase Inhibitor 5-24 amide (Echelon Bioscience, CAT#891-14) |
| cAMP Dependent Protein Kinase Inhibitor PKI-tide (Echelon Bioscience, CAT#892-20) |
| Cardioexcitatory Peptide, African giant snail (Echelon Bioscience, CAT#610-74) |
| Cardiolipin Beads (Echelon Bioscience, CAT#P-BCLP) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-56) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-52) |
| Cathepsin D and E substrate, fluorogenic (Echelon Bioscience, CAT#866-41) |
| Cathepsin D Substrate (Echelon Bioscience, CAT#880-42) |
| Cathepsin L Inhibitor (Echelon Bioscience, CAT#866-23) |
| Cathepsin S Substrate, fluorogenic (Echelon Bioscience, CAT#866-80) |
| CDP-ME Kinase (IspE) (Echelon Bioscience, CAT#E-2000E) |
| CDP-ME Synthase (IspD) (Echelon Bioscience, CAT#E-2000D) |
| CDP-ME Synthase (IspD) Enzymatic Assay (Echelon Bioscience, CAT#K-2000D) |
| CDP-MEP Synthesis Kit (Echelon Bioscience, CAT#K-2000E) |
| Cecropin B (Echelon Bioscience, CAT#893-50) |
| Cecropin P1, porcine (Echelon Bioscience, CAT#893-60) |
| Cell Adhesion Inhibitor Peptide, cyclic (Echelon Bioscience, CAT#451-40) |
| Cell Permeable Caspase 1 Inhibitor (Echelon Bioscience, CAT#864-38) |
| Cell Permeable Caspase 3 Inhibitor (Echelon Bioscience, CAT#864-29) |
| Cell Permeable Caspase 6 Inhibitor (Echelon Bioscience, CAT#864-31) |
| Ceramide 1-Phosphate (C1P) Beads (Echelon Bioscience, CAT#P-BC1P) |
| Ceramide Beads (Echelon Bioscience, CAT#P-BCER) |
| Ceranib-2 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0043) |
| cGMP Dep. Protein Kinase Substrate (BPDEide) (Echelon Bioscience, CAT#870-78) |
| Charybdotoxin, cyclic (Echelon Bioscience, CAT#429-60) |
| Chemotactic Peptide (Formyl-Met-Leu-Phe-OH) (Echelon Bioscience, CAT#850-15) |
| Chitin Polymer (Echelon Bioscience, CAT#H-10CH) |
| Cholecystokinin Octapeptide (26-33) / CCK 8 (Echelon Bioscience, CAT#471-47) |
| Cholecystokinin Octapeptide (26-33) Non-Sulfated / CCK-NSE O (Echelon Bioscience, CAT#471-48) |
| Cholesterol (Echelon Bioscience, CAT#L-6012) |
| Cholesterol Beads (Echelon Bioscience, CAT#P-BCHL) |
| Chromogranin A (324-337) WE 14, human (Echelon Bioscience, CAT#474-70) |
| Cionin (Echelon Bioscience, CAT#477-49) |
| Class I PI3-Kinase Reaction Buffer (Echelon Bioscience, CAT#K-KBZ) |
| Class III PI3K ELISA Kit (Echelon Bioscience, CAT#K-3000) |
| cMEPP Synthase (IspF) (Echelon Bioscience, CAT#E-2000F) |
| CML ELISA Kit II (Echelon Bioscience, CAT#K-3900S) |
| Coagulation Factor XIIIA (72-97) (Echelon Bioscience, CAT#459-15) |
| Colipase Activation Peptide (Echelon Bioscience, CAT#873-30) |
| Collagen Hybridizing Peptide – Biotin conjugate (CHP) (Echelon Bioscience, CAT#BIO) |
| Collagen Hybridizing Peptide – Cy3 Conjugate (Echelon Bioscience, CAT#RED) |
| Collagen Hybridizing Peptide – Fluorescein Conjugate (Echelon Bioscience, CAT#FLU) |
| Control Beads (Echelon Bioscience, CAT#P-B000) |
| Control PolyPIPosomes (Echelon Bioscience, CAT#Y-0000) |
| Corazonin, Periplaneta Americana (Echelon Bioscience, CAT#619-47) |
| Corticotropin Releasing Factor (CRF) human, rat (Echelon Bioscience, CAT#351-25) |
| Corticotropin Releasing Factor [Tyr0], ovine / CRF [Tyr0], o (Echelon Bioscience, CAT#352-37) |
| Corticotropin Releasing Factor, bovine, CRF, bovine (Echelon Bioscience, CAT#353-26) |
| Corticotropin Releasing Factor, ovine / CRF, ovine (Echelon Bioscience, CAT#352-26) |
| Cova PIP Screening Plate (Echelon Bioscience, CAT#H-6200) |
| CREBtide (Echelon Bioscience, CAT#890-15) |
| Cu(II) Protoporphyrin IX, 14494-37-2 (Echelon Bioscience, CAT#F-H070) |
| Custom Lipid Array Strip (Echelon Bioscience, CAT#P-6111) |
| CYM50308 (S1P4 Receptor Agonist) (Echelon Bioscience, CAT#B-0060) |
| D-erythro-Sphingosine (Echelon Bioscience, CAT#S-1000) |
| D-Ile-Pro-Arg-AMC (Echelon Bioscience, CAT#855-18) |
| D-Ile-Pro-Arg-pNA (Echelon Bioscience, CAT#855-19) |
| D-Phe-Pro-Lys-pNA (Thrombin Substrate colorimetric) (Echelon Bioscience, CAT#885-49) |
| D-sn-1-O-oleoyl-2-O-methylglyceryl-3-phosphothionate (2R-OMPT) (Echelon Bioscience, CAT#L-9318) |
| D-Val-Gly-Arg-pNA (Echelon Bioscience, CAT#855-31) |
| D-Val-Leu-Arg-AFC (Kallikrein substrate, fluorogenic) (Echelon Bioscience, CAT#871-84) |
| D-Val-Leu-Arg-AMC (Kallikrein Substrate, fluorogenic) (Echelon Bioscience, CAT#871-81) |
| D-Val-Leu-Arg-pNA (Kallikrein Substrate, colorimetric) (Echelon Bioscience, CAT#871-82) |
| D-Val-Leu-Lys-AFC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-22) |
| D-Val-Leu-Lys-AMC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-18) |
| D-Val-Leu-Lys-pNA (Plasmin substrate colorimetric) (Echelon Bioscience, CAT#872-21) |
| D-Val-Lys-Lys-Arg-AMC (Echelon Bioscience, CAT#855-44) |
| d5-PAPEth (Echelon Bioscience, CAT#L-6055) |
| d5-PLPEth (Echelon Bioscience, CAT#L-6052) |
| d5-POPEth (Echelon Bioscience, CAT#L-6051) |
| d5-SLPEth (Echelon Bioscience, CAT#L-6054) |
| d5-SOPEth (Echelon Bioscience, CAT#L-6053) |
| DAPC (20:0 PC) (Echelon Bioscience, CAT#L-1120) |
| DBPC (PLA2 Substrate) (Echelon Bioscience, CAT#L-3000) |
| Decorsin, Leech (Macrobdella decora) (Echelon Bioscience, CAT#459-10) |
| Decyl Rhamnoside (Echelon Bioscience, CAT#RL10-1) |
| Dermaseptin (Echelon Bioscience, CAT#889-15) |
| DES1 Inhibitor (Echelon Bioscience, CAT#B-0027) |
| Desmopressin, [D-Gln4] Disulfide Bridge 1-6, Acetate (Echelon Bioscience, CAT#671-18) |
| Desmopressin, [L-Arg8], Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-20) |
| Desmopressin, Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-19) |
| DHPS (6:0/6:0 PS) (Echelon Bioscience, CAT#L-3106) |
| Dibromobimane (Echelon Bioscience, CAT#F-0040) |
| Dilauroyl-sn-glycerol (Echelon Bioscience, CAT#L-0012) |
| Dimethylallyl Diphosphate (DMAPP) (Echelon Bioscience, CAT#I-0051) |
| Dimethylallyl S-Thiolodiphosphate (DMASPP) (Echelon Bioscience, CAT#I-S051) |
| Dimyristoyl-sn-glycerol (Echelon Bioscience, CAT#L-0014) |
| Dipalmitoyl-sn-glycerol (Echelon Bioscience, CAT#L-0016) |
| DLPA (12:0/12:0 PA) (Echelon Bioscience, CAT#L-4112) |
| DLPC (12:0/12:0 PC) (Echelon Bioscience, CAT#L-1112) |
| DLPE (12:0/12:0 PE) (Echelon Bioscience, CAT#L-2112) |
| DLPG (12:0/12:0 PG) (Echelon Bioscience, CAT#L-5112) |
| DMOG (dimethyloxalylglycine) (Echelon Bioscience, CAT#F-0010) |
| DMPA (14:0/14:0 PA) (Echelon Bioscience, CAT#L-4114) |
| DMPC (14:0/14:0 PC) (Echelon Bioscience, CAT#L-1114) |
| DMPE (14:0/14:0 PE) (Echelon Bioscience, CAT#L-2114) |
| DMPG (14:0/14:0 PG) (Echelon Bioscience, CAT#L-5114) |
| Dnp-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-OH (MMP 8 Substrate) (Echelon Bioscience, CAT#868-44) |
| Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH (MMP-2 / MMP-9 Substrate) (Echelon Bioscience, CAT#865-10) |
| DOPC (18:1/18:1 PC) (Echelon Bioscience, CAT#L-1182) |
| DOPE (18:1/18:1 PE) (Echelon Bioscience, CAT#L-2182) |
| DOPEth (18:1/18:1 PEth) (Echelon Bioscience, CAT#L-6018) |
| DPePC (Echelon Bioscience, CAT#L-1162) |
| DPPA (16:0/16:0 PA) (Echelon Bioscience, CAT#L-4116) |
| DPPC (16:0/16:0 PC) (Echelon Bioscience, CAT#L-1116) |
| DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2116) |
| DPPG (16:0/16:0 PG) (Echelon Bioscience, CAT#L-5116) |
| DPPS (16:0/16:0 PS) (Echelon Bioscience, CAT#L-3116) |
| DSPA (18:0/18:0 PA) (Echelon Bioscience, CAT#L-4118) |
| DSPC (18:0 PC) (Echelon Bioscience, CAT#L-1118) |
| DSPE (18:0/18:0 PE) (Echelon Bioscience, CAT#L-2118) |
| DSPG (18:0/18:0 PG) (Echelon Bioscience, CAT#L-5118) |
| DXP Synthase (DXS) (Echelon Bioscience, CAT#E-20DXS) |
| Dynorphin A (1-8), porcine (Echelon Bioscience, CAT#274-82) |
| Dynorphin A, porcine [Prodynorphin (209-225)] (Echelon Bioscience, CAT#274-27) |
| Dynorphin B, porcine / Rimorphin / Prodynorphin (228-240) (Echelon Bioscience, CAT#274-50) |
| ECE-1 Substrate (Echelon Bioscience, CAT#331-72) |
| Endomorphin I (Echelon Bioscience, CAT#311-88) |
| Endomorphin II (Echelon Bioscience, CAT#311-89) |
| Endothelin 2, human / ET 2 (Echelon Bioscience, CAT#331-20) |
| Endothelin 1, human (Echelon Bioscience, CAT#331-25) |
| Endothelin 3, cyclic (human, mouse, rabbit, rat) (Echelon Bioscience, CAT#335-10) |
| Endothelin Antagonist BQ 123, cyclic (Echelon Bioscience, CAT#331-10) |
| Endothelin Antagonist PD 142893 (Echelon Bioscience, CAT#331-17) |
| Endothelin Beta Receptor Agonist IRL 1620 (Echelon Bioscience, CAT#331-11) |
| Endothelin Beta Receptor Antagonist IRL 1038 (Echelon Bioscience, CAT#331-13) |
| Endothelin Receptor Antagonist BQ 3020 / Acetyl-(Ala11,15)-ET (Echelon Bioscience, CAT#331-14) |
| Endothelin Receptor Antagonist W 7338A (Echelon Bioscience, CAT#331-16) |
| Enkephalin Analog (Echelon Bioscience, CAT#311-55) |
| Enkephalinamide [D-Met2,Pro5] (Echelon Bioscience, CAT#310-47) |
| Epidermal Growth Factor (20-31) [Cys (Acm 20,31)] / EGF (Echelon Bioscience, CAT#510-50) |
| ET A Receptor Antagonist JKC 301 (Echelon Bioscience, CAT#331-51) |
| ET Antagonist PD 156252 (Echelon Bioscience, CAT#331-19) |
| ET Receptor Antagonist (PD 145065) (Echelon Bioscience, CAT#331-18) |
| Ether C12 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B120E) |
| Ether C18 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B180E) |
| Exendin 3 (Echelon Bioscience, CAT#507-79) |
| Exendin 3 (9-39) Fragment (Echelon Bioscience, CAT#507-81) |
| Exendin 4 (Echelon Bioscience, CAT#507-77) |
| ExoClean – EV Purification Kit (Echelon Bioscience, CAT#K-4300a) |
| ExoTracker – Membrane (Echelon Bioscience, CAT#K-4300b) |
| ExoTracker – RNA (Echelon Bioscience, CAT#K-4300c) |
| ExoTracker – Total (Echelon Bioscience, CAT#K-4300d) |
| Extracellular Death Factor (Echelon Bioscience, CAT#950-10) |
| Farnesyl Diphosphate (FPP) (Echelon Bioscience, CAT#I-0150) |
| Farnesyl S-Thiolodiphosphate (FSPP) (Echelon Bioscience, CAT#I-S150) |
| Fibrinogen Binding Inhibitory Peptide (Echelon Bioscience, CAT#431-55) |
| Fibrinogen Fragment (Echelon Bioscience, CAT#450-16) |
| Fibrinopeptide A [Tyr0], human (Echelon Bioscience, CAT#431-31) |
| Fibrinopeptide B [Glu1], (human) (Echelon Bioscience, CAT#431-39) |
| Fibrinopeptide B, human (Echelon Bioscience, CAT#431-36) |
| Fibronectin Fragment (Echelon Bioscience, CAT#450-59) |
| Flow PIPs: Multiplex Lipid Beads (Echelon Bioscience, CAT#P-FB01) |
| Fluorescein conjugated Anti-PI(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-G345) |
| Fluorescein conjugated Anti-PI(4,5)P2 IgM (Echelon Bioscience, CAT#Z-G045) |
| Fluorescein Monolysocardiolipin (Echelon Bioscience, CAT#L-M16F) |
| Fluorescent Carrier Pack (Echelon Bioscience, CAT#P-9CFL) |
| FPA-124 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0101) |
| FR-1, cyclic (Echelon Bioscience, CAT#450-53) |
| FR900098 (Echelon Bioscience, CAT#B-4202) |
| FS-3 (LysoPLD / Autotaxin substrate) (Echelon Bioscience, CAT#L-2000) |
| FTY720 (Echelon Bioscience, CAT#B-0720) |
| Furin Inhibitor II (Echelon Bioscience, CAT#855-10) |
| G-Subtide (Echelon Bioscience, CAT#871-15) |
| Galanin, rat (Echelon Bioscience, CAT#475-25) |
| Galanin, human (Echelon Bioscience, CAT#471-22) |
| Galanin, porcine (Echelon Bioscience, CAT#471-25) |
| Galantide (Echelon Bioscience, CAT#471-02) |
| Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-27) |
| Ganirelix (Echelon Bioscience, CAT#557-31) |
| Gastric Inhibitory Peptide (GIP), human (Echelon Bioscience, CAT#471-75) |
| Gastrin (1-17) [Gly18], human (Echelon Bioscience, CAT#471-89) |
| Gastrin (2-17) [Leu15,Gly18] / MSI 1771 (Echelon Bioscience, CAT#471-83) |
| Gastrin I (1-14) (Echelon Bioscience, CAT#471-79) |
| Gastrin I, human (Echelon Bioscience, CAT#471-73) |
| Gastrin II SE, human (Echelon Bioscience, CAT#471-74) |
| Gastrin Releasing Peptide, human / GRP, h (Echelon Bioscience, CAT#471-85) |
| Geranyl Diphosphate (GPP) (Echelon Bioscience, CAT#I-0100) |
| Geranyl S-Thiolodiphosphate (GSPP) (Echelon Bioscience, CAT#I-S100) |
| Geranylgeranyl Diphosphate (GGPP) (Echelon Bioscience, CAT#I-0200) |
| Geranylgeranyl S-thiodiphosphate (GGSPP) (Echelon Bioscience, CAT#I-S200) |
| Ghrelin (rat) (Echelon Bioscience, CAT#551-15) |
| Ghrelin, human (Echelon Bioscience, CAT#551-10) |
| GloPIPs Biotin-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6A) |
| GloPIPs Biotin-PI(3,4)P2 (Echelon Bioscience, CAT#C-34B6A) |
| GloPIPs Biotin-PI(3,5)P2 (Echelon Bioscience, CAT#C-35B6A) |
| GloPIPs Biotin-PI(3)P (Echelon Bioscience, CAT#C-03B6A) |
| GloPIPs Biotin-PI(4,5)P2 (Echelon Bioscience, CAT#C-45B6a) |
| GloPIPs Biotin-PI(4)P (Echelon Bioscience, CAT#C-04B6A) |
| GloPIPs Biotin-PI(5)P (Echelon Bioscience, CAT#C-05B6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3, C16 (Echelon Bioscience, CAT#C-39F16A) |
| GloPIPs BODIPY FL-PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2 (Echelon Bioscience, CAT#C-45F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2, C16 (Echelon Bioscience, CAT#C-45F16A) |
| GloPIPs BODIPY FL-PI(4)P (Echelon Bioscience, CAT#C-04F6A) |
| GloPIPs BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6A) |
| GloPIPs BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6A) |
| GloPIPs BODIPY TMR-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6A) |
| GloPIPs BODIPY TMR-PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2 (Echelon Bioscience, CAT#C-45M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2, C16 (Echelon Bioscience, CAT#C-45M16A) |
| GLP 2 [Gly2], human (Echelon Bioscience, CAT#471-21) |
| GLP 2 [Tyr34] (1-34), human (Echelon Bioscience, CAT#471-19) |
| GLP-1 (9-36) , Glucagon-like Peptide 1 (Echelon Bioscience, CAT#471-42) |
| Glp-Pro-Val-pNA (Human Granulocyte Elastase Substrate, colorimetric) (Echelon Bioscience, CAT#871-19) |
| Glu-His-Tyr-Gln-AMC (Echelon Bioscience, CAT#877-01) |
| Glucagon-like Peptide-1, GLP-1 (7-36) / Preproglucagon (78-107) amide (Echelon Bioscience, CAT#471-28) |
| Glucagon-like Peptide-1, GLP-1 (7-37) human (Echelon Bioscience, CAT#471-39) |
| Glucagon-like Peptide-1, GLP-1 (Preproglucagon 72-107) amide (Echelon Bioscience, CAT#471-27) |
| Glucagon-like Peptide-1, human (Echelon Bioscience, CAT#471-26) |
| Glucagon-like Peptide-2, GLP-2 (1-33), rat / Preproglucagon (126-158) (Echelon Bioscience, CAT#471-23) |
| Glucagon-like Peptide-2, GLP-2, human / Preproglucagon (126-158), human (Echelon Bioscience, CAT#471-18) |
| Glucagon, human (Echelon Bioscience, CAT#471-30) |
| Gly-Arg-Ala-Asp-Ser-Pro (GRADSP) (Echelon Bioscience, CAT#450-36) |
| Gly-Arg-Gly-Asp-Ser (GRGDS) (Echelon Bioscience, CAT#450-38) |
| Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) (Echelon Bioscience, CAT#450-39) |
| Gly-Pro-Arg-Pro-NH2 (Echelon Bioscience, CAT#450-17) |
| Glycerophosphoinositol 5-phosphate (Gro PI(5)P) (Echelon Bioscience, CAT#P-5000) |
| GMAP (1-41), amide / Galanin Message Associated Peptide (1-41), amide (Echelon Bioscience, CAT#421-35) |
| Goat anti-human Autotaxin antibody (Echelon Bioscience, CAT#Z-P400) |
| Granuliberin R (Echelon Bioscience, CAT#880-87) |
| Granzyme A Substrate, fluorogenic (Echelon Bioscience, CAT#874-13) |
| GRF (1-44)NH2, bovine (Echelon Bioscience, CAT#535-15) |
| GRF, mouse (Echelon Bioscience, CAT#536-10) |
| GRI977143 (LPA2 Agonist) (Echelon Bioscience, CAT#B-0070) |
| GroPI (Echelon Bioscience, CAT#P-0000) |
| GroPI(3,4,5)P3 (Echelon Bioscience, CAT#P-3900) |
| GroPI(4,5)P2 (Echelon Bioscience, CAT#P-4500) |
| GroPI(4)P (Echelon Bioscience, CAT#P-4000) |
| Growth Hormone Releasing Factor [D-Ala2] (1-29) amide, human (Echelon Bioscience, CAT#531-76) |
| Growth Hormone Releasing Factor [His1,Nle27] (1-32) amide, human (Echelon Bioscience, CAT#531-74) |
| Growth Hormone Releasing Factor (1-29) amide, human / GRF (1-29), amide, human (Echelon Bioscience, CAT#531-75) |
| Growth Hormone Releasing Factor (1-40) amide, human; GRF (1-40) amide, human (Echelon Bioscience, CAT#531-67) |
| Growth Hormone Releasing Factor (1-40), human; GRF (1-40), human (Echelon Bioscience, CAT#531-68) |
| Growth Hormone Releasing Factor (1-44), porcine / GRF (1-44), porcine (Echelon Bioscience, CAT#534-29) |
| Growth Hormone Releasing Factor / GRF [Ac-Tyr1,D-Arg2] (1-29) amide (Echelon Bioscience, CAT#531-84) |
| Growth Hormone Releasing Factor, GRF (1-44) amide, human (Echelon Bioscience, CAT#531-66) |
| Growth Hormone Releasing Peptide 6 (GHRP-6) / GHRP [His1, Lys6] (Echelon Bioscience, CAT#531-18) |
| HA130 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0701) |
| HA30-BODIPY-FL (Echelon Bioscience, CAT#H-025F) |
| HA30-TexasRed (Echelon Bioscience, CAT#H-025R) |
| HA300-BODIPY-FL (Echelon Bioscience, CAT#H-250F) |
| HA300-TexasRed (Echelon Bioscience, CAT#H-250R) |
| HA850-BODIPY-FL (Echelon Bioscience, CAT#H-700F) |
| HA850-TexasRed (Echelon Bioscience, CAT#H-700R) |
| Helodermin [Gln8,9] (Echelon Bioscience, CAT#740-27) |
| Hemagglutination Inhibiting Peptide, human;from parotid secr (Echelon Bioscience, CAT#790-10) |
| Heme Oxygenase Inhibitor Toolbox (Echelon Bioscience, CAT#F-HOIT) |
| Hemin (Echelon Bioscience, CAT#F-H010) |
| Heparin ELISA (Echelon Bioscience, CAT#K-5300) |
| Hepatitis C Virus NS3 Protease Substrate, fluorogenic (Echelon Bioscience, CAT#732-35) |
| Herpes Virus Inhibitor 1 (Echelon Bioscience, CAT#732-36) |
| Herpes Virus Inhibitor 2 (Echelon Bioscience, CAT#872-39) |
| Hexadecyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0320) |
| High Mobility Group Box 1 (HMGB1) (Echelon Bioscience, CAT#G-HMGB1) |
| High Throughput Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200HTS) |
| Hirudin (54-65), Sulfated (Echelon Bioscience, CAT#873-20) |
| Hirudin Acetyl (54-65) Sulfated (Echelon Bioscience, CAT#873-15) |
| Histidine Tagged Versican G1 Domain (Echelon Bioscience, CAT#G-HA03) |
| Histone H2B (29-35) (Echelon Bioscience, CAT#870-75) |
| HIV Envelope Peptide GP 120, (307-330) (Echelon Bioscience, CAT#870-26) |
| HIV Substrate IV (Echelon Bioscience, CAT#870-15) |
| HIV-1 Protease Substrate (Echelon Bioscience, CAT#870-10) |
| HIV-TAT 48-57 JNK Inhibitor I (Echelon Bioscience, CAT#732-10) |
| HS014 / MSH Antagonist cyclic / File # 0045A (Echelon Bioscience, CAT#571-72) |
| Human Lysosomal Phospholipase A2 (hLPLA2), active (Echelon Bioscience, CAT#E-7000) |
| Humanin, human (Echelon Bioscience, CAT#640-52) |
| Hy-Pip Cova PIP Specificity Plate (Echelon Bioscience, CAT#H-6300) |
| Hyaluronan Enzyme-Linked Immunosorbent Assay (HA ELISA) (Echelon Bioscience, CAT#K-1200) |
| Hyaluronic Acid (HA) Screening Service (Echelon Bioscience, CAT#T-1200) |
| Hyaluronic Acid Sandwich ELISA (Echelon Bioscience, CAT#K-4800) |
| Hyaluronidase Activity ELISA (Echelon Bioscience, CAT#K-6000) |
| Hypertrehalosaemic Neuropeptide, german cockroach (Nauphoeta (Echelon Bioscience, CAT#619-58) |
| IC87114 (PI3-K delta inhibitor) (Echelon Bioscience, CAT#B-0305) |
| IGRP Catalytic Subunit (206-214) (Echelon Bioscience, CAT#471-58) |
| Innate Defense Regulator 1018 (IDR-1018) (Echelon Bioscience, CAT#745-20) |
| Inositol 1,2,6-trisphosphate (Ins(1,2,6)P3) (Echelon Bioscience, CAT#Q-0126) |
| Inositol 1,3-bisphosphate (Ins(1,3)P2) (Echelon Bioscience, CAT#Q-0013) |
| Inositol 1,3,4-trisphosphate (Ins(1,3,4)P3) (Echelon Bioscience, CAT#Q-0134) |
| Inositol 1,3,5-trisphosphate (Ins(1,3,5)P3) (Echelon Bioscience, CAT#Q-0135) |
| Inositol 1,4-bisphosphate (Ins(1,4)P2) (Echelon Bioscience, CAT#Q-0014) |
| Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) (Echelon Bioscience, CAT#Q-0145) |
| Inositol 1,5-bisphosphate (Ins(1,5)P2) (Echelon Bioscience, CAT#Q-0015) |
| INPP4 Activity Kit (Echelon Bioscience, CAT#K-5200) |
| INPP4A, active (Echelon Bioscience, CAT#E-8000) |
| Ins(1,3,4,5)P4 (Echelon Bioscience, CAT#Q-1345) |
| Ins(1,3,4,5)P4 Beads (Echelon Bioscience, CAT#Q-B1345) |
| Ins(1,3,4,5)P4 Biotin (Echelon Bioscience, CAT#Q-139B) |
| Ins(1,3,4,6)P4 (Echelon Bioscience, CAT#Q-1346) |
| Ins(1,4,5)P3 Beads (Echelon Bioscience, CAT#Q-B0145) |
| Ins(1,4,5)P3 Biotin (Echelon Bioscience, CAT#Q-145B) |
| IP3 Receptor Inhibitor 911 [Diphenyl (2,6-diaminohexanoate-O,N)-borane] (Echelon Bioscience, CAT#B-0370) |
| Isopentenyl Diphosphate (IPP) (Echelon Bioscience, CAT#I-0050) |
| Isopentenyl S-Thiolodiphosphate (ISPP) (Echelon Bioscience, CAT#I-S050) |
| IspF Inhibitor 1 (Echelon Bioscience, CAT#B-4102) |
| Juvenile Hormone III (racemic) (Echelon Bioscience, CAT#S-0155) |
| K118 (SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0344) |
| K149 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0345) |
| Kemptide (Phosphate Acceptor Peptide) (Echelon Bioscience, CAT#870-65) |
| Ki16425 (LPA Receptor Antagonist) (Echelon Bioscience, CAT#B-0730) |
| KISS (107-121) (Echelon Bioscience, CAT#548-19) |
| KISS (112-121) (Echelon Bioscience, CAT#548-17) |
| KISS-1 (125-144) (Echelon Bioscience, CAT#548-21) |
| KISS-1 (58-65) (Echelon Bioscience, CAT#548-11) |
| KISS-1 (68-80) (Echelon Bioscience, CAT#548-13) |
| KISS-1 (68-91) (Echelon Bioscience, CAT#548-14) |
| KISS-1 (94-121) (Echelon Bioscience, CAT#548-12) |
| KP372-1 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0102) |
| L-Ascorbyl-6-stearate (Echelon Bioscience, CAT#R-1218) |
| Lactosylceramide (LacCer) Beads (Echelon Bioscience, CAT#P-B0LC) |
| Laminin (929-933) (Echelon Bioscience, CAT#736-21) |
| Laminin A (2091-2108) (Echelon Bioscience, CAT#736-10) |
| LBPA Beads (Echelon Bioscience, CAT#P-BLBPA) |
| Leu-Enkephalin (Echelon Bioscience, CAT#310-75) |
| Leu-Enkephalin [D-Ala2] (Echelon Bioscience, CAT#310-84) |
| Leucokinin I (Echelon Bioscience, CAT#341-29) |
| Leumorphin (human) (Preproenkephalin B 226-254) (Echelon Bioscience, CAT#271-35) |
| LH-RH [D-Ala6] (Echelon Bioscience, CAT#550-44) |
| LH-RH [D-Lys6] (Echelon Bioscience, CAT#550-46) |
| LH-RH [D-Lys6] Free Acid (Echelon Bioscience, CAT#551-46) |
| LH-RH [D-Phe2,D-Ala6] (Echelon Bioscience, CAT#550-45) |
| LH-RH [Hyp9] (Echelon Bioscience, CAT#557-45) |
| LH-RH Free Acid (Echelon Bioscience, CAT#551-27) |
| LH-RH II alligator, chicken (Echelon Bioscience, CAT#558-39) |
| Linolenoyl LPA, 18:3 LPA (Echelon Bioscience, CAT#L-0183) |
| Linoleoyl LPA-d5, 18:2 LPA-d5 (Echelon Bioscience, CAT#L-0182d) |
| Linoleoyl LPA, 18:2 LPA (Echelon Bioscience, CAT#L-0182) |
| Locustapyrokinin [Glu6], Locusta Migratoria (Echelon Bioscience, CAT#361-26) |
| Locustapyrokinin, L. Migratoria (Echelon Bioscience, CAT#361-25) |
| LPA Beads (Echelon Bioscience, CAT#L-6101) |
| LPA Biotin (Echelon Bioscience, CAT#L-012B) |
| LPA ELISA Assay Service (Echelon Bioscience, CAT#T-2800S) |
| LPLA2 Activity Assay (Echelon Bioscience, CAT#K-7000A) |
| LPLA2 Inhibitor Screen (Echelon Bioscience, CAT#K-7000I) |
| LPS (16:0) (Echelon Bioscience, CAT#L-3216) |
| LY294002 (PI3-K Inhibitor) (Echelon Bioscience, CAT#B-0294) |
| Lysophosphatidic Acid Antibody (504B3) (Echelon Bioscience, CAT#Z-P200) |
| Lysophosphatidic Acid ELISA Kit (Echelon Bioscience, CAT#K-2800S) |
| LysoPI, 16:0 LPI (Echelon Bioscience, CAT#P-0160) |
| Malachite Green Assay Kit (Echelon Bioscience, CAT#K-1500) |
| Malachite Green Solution (Echelon Bioscience, CAT#K-1501) |
| Mast Cell Degranulating Peptide HR-1 (Echelon Bioscience, CAT#429-35) |
| Mast Cell Degranulating Peptide HR-2 (Echelon Bioscience, CAT#429-37) |
| Mastoparan, hornet Vespa basalis (Echelon Bioscience, CAT#887-20) |
| Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(DNP)-OH (Caspase 1 Substrate) (Echelon Bioscience, CAT#865-21) |
| Mca-Val-Asp-Val-Ala-Asp-Gly-Trp-Lys(DNP)-NH2 (Caspase 2 (ICH-1) Substrate ) (Echelon Bioscience, CAT#866-10) |
| Melanotan II, cyclic α-MSH (Echelon Bioscience, CAT#571-56) |
| Melittin (Echelon Bioscience, CAT#920-32) |
| Membrane Lipid Arrays (Echelon Bioscience, CAT#P-6003) |
| Membrane Lipid Strips (Echelon Bioscience, CAT#P-6002) |
| MeOSuc-Ala-Ala-Pro-Val-4MbNA (Pancreatic Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-19) |
| MeOSuc-Ala-Ala-Pro-Val-AFC Pancreatic Leukocyte Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-17) |
| MEP Synthase (DXR) Enzyme Inhibitor Screen (Echelon Bioscience, CAT#K-2000C) |
| MEP Synthase (DXR), active (Echelon Bioscience, CAT#E-2000C) |
| Mesobiliverdin (microbial sourced) (Echelon Bioscience, CAT#F-H160) |
| Met Enkephalin [Lys 6] (Echelon Bioscience, CAT#310-59) |
| Metastin, KISS -1 (68-121) (Echelon Bioscience, CAT#548-25) |
| Methoxysuccinyl-Ala-Ala-Arg-pNA (Echelon Bioscience, CAT#876-07) |
| Methoxysuccinyl-Pro-Ser-Pro-Phe-AMC (Echelon Bioscience, CAT#877-02) |
| Methyl glucoside sesquistearate (Echelon Bioscience, CAT#R-1018) |
| MG-115 (Proteasome Inhibitor) (Echelon Bioscience, CAT#882-10) |
| MG-132 Proteasome Inhibitor (Echelon Bioscience, CAT#882-11) |
| Miltefosine (Echelon Bioscience, CAT#L-1216) |
| Mini Gastrin I, human (Echelon Bioscience, CAT#471-11) |
| MMP 13 Substrate, fluorogenic (Echelon Bioscience, CAT#868-30) |
| MMP 14 substrate Stomelysine-3, fluorogenic (Echelon Bioscience, CAT#868-42) |
| MMP 2 Substrate, fluorogenic (Echelon Bioscience, CAT#868-20) |
| MMP Inhibitor I (Echelon Bioscience, CAT#868-75) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-22) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-41) |
| MMP-3 Inhibitor 1 (Echelon Bioscience, CAT#868-60) |
| MMP-3 Substrate, fluorogenic (Echelon Bioscience, CAT#868-62) |
| MMV008138(1R,3S) (IspD Inhibitor) (Echelon Bioscience, CAT#B-4103) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, human (Echelon Bioscience, CAT#651-10) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, rat (Echelon Bioscience, CAT#645-10) |
| MOG Protein (68-84), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, guinea pig (Echelon Bioscience, CAT#920-63) |
| Monobromobimane (Echelon Bioscience, CAT#F-0030) |
| Monocaprin (Echelon Bioscience, CAT#L-9010) |
| Monolaurin (Echelon Bioscience, CAT#L-9012) |
| Monomyristin (Echelon Bioscience, CAT#L-9014) |
| MOPC (17:0/18:1 PC) (Echelon Bioscience, CAT#L-1117) |
| MOPEth (17:0/18:1 PEth) (Echelon Bioscience, CAT#L-6017) |
| Morphine Modulating Neuropeptide (Echelon Bioscience, CAT#340-79) |
| Motilin, dog (Echelon Bioscience, CAT#496-25) |
| Motilin, human (Echelon Bioscience, CAT#491-15) |
| ms-PtdIns(4,5)P2 diC16 (Echelon Bioscience, CAT#P-F4516) |
| ms-PtdIns(4,5)P2 diC8 (Echelon Bioscience, CAT#P-F4508) |
| MultiPIP Grip (Echelon Bioscience, CAT#G-9901) |
| Myelin Proteolipid Protein (139-151) [Ser 140] (depalmitoylated), h, b, d, m, r (Echelon Bioscience, CAT#720-10) |
| Myosin Light Chain Kinase (11-19) amide (Echelon Bioscience, CAT#892-96) |
| Myosin Light Chain Kinase Substrate (Smooth muscle) (Echelon Bioscience, CAT#930-30) |
| MZ-4-169 (Echelon Bioscience, CAT#531-92) |
| MZ-4-181 (Echelon Bioscience, CAT#531-93) |
| MZ-4-71 (Echelon Bioscience, CAT#531-91) |
| N-Acetyl Beta Endorphin, human (Echelon Bioscience, CAT#291-29) |
| N-arachidonoyl-DPPE (NAPE 20:4) (Echelon Bioscience, CAT#L-2404) |
| N-Biotin Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500B) |
| N-Linoleoyl-DPPE (Echelon Bioscience, CAT#L-2420) |
| N-NBD Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500N6) |
| N-Oleoyl-DPPE (Echelon Bioscience, CAT#L-2419) |
| N-palmitoyl-DPPE (NAPE 16:0) (Echelon Bioscience, CAT#L-2416) |
| N-Stearoyl Ceramide 1-phosphate (Echelon Bioscience, CAT#S-5018) |
| N-Stearoyl-DPPE (Echelon Bioscience, CAT#L-2418) |
| nanoHA-5 (Echelon Bioscience, CAT#HYA-NANO5-1) |
| NBD-Phosphatidylethanol (Echelon Bioscience, CAT#L-60N16) |
| NeoBeads – PIP Purification System (Echelon Bioscience, CAT#P-B999) |
| Neryl Diphosphate (NPP) (Echelon Bioscience, CAT#I-0120) |
| Neurokinin A [Tyr5,DTrp6,8,9Lys10] (4-10) (Echelon Bioscience, CAT#631-70) |
| Neurokinin A [Ala5, BetaAla8],(4-10) (Echelon Bioscience, CAT#631-65) |
| Neuromedin B (Echelon Bioscience, CAT#630-62) |
| Neuromedin N (Echelon Bioscience, CAT#634-46) |
| Neuromedin U-8 (Echelon Bioscience, CAT#630-65) |
| Neuropeptide Y (3-36), human, rat / NPY (3-36) (Echelon Bioscience, CAT#614-41) |
| Neuropeptide Y (3-36), porcine / NPY (3-36) (Echelon Bioscience, CAT#614-39) |
| Neuropeptide Y (human, rat) (Echelon Bioscience, CAT#611-26) |
| Neuropeptide Y, porcine / NPY, porcine (Echelon Bioscience, CAT#614-30) |
| Neurotensin [D-Trp11] (Echelon Bioscience, CAT#631-38) |
| Neurotensin, human (Echelon Bioscience, CAT#631-27) |
| Neutral Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-1800) |
| Neutral Sphingomyelinase Assay Service (Echelon Bioscience, CAT#T-1800) |
| NFF 2 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-25) |
| NFF 3 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-10) |
| Nociceptin/Orphanin FQ (Echelon Bioscience, CAT#310-78) |
| NOG (N-oxalylglycine) (Echelon Bioscience, CAT#F-0020) |
| Non-A-Beta Component Amyloid (Echelon Bioscience, CAT#641-80) |
| Nonfluorescent Carrier Pack (Echelon Bioscience, CAT#P-9C00) |
| NVP-231 (Ceramide Kinase Inhibitor) (Echelon Bioscience, CAT#B-0040) |
| Obestatin (11-23), mouse (Echelon Bioscience, CAT#475-96) |
| Obestatin, human (Echelon Bioscience, CAT#471-97) |
| Obestatin, mouse (Echelon Bioscience, CAT#475-97) |
| Octreotide (Echelon Bioscience, CAT#690-44) |
| Oleoyl 3-carbacyclic Phosphatidic Acid (Echelon Bioscience, CAT#L-7218) |
| Oleoyl LPA, 18:1 LPA (Echelon Bioscience, CAT#L-0181) |
| Oral Formulation Vehicle (Echelon Bioscience, CAT#B-0706) |
| Orexin A (human, rat, mouse) (Echelon Bioscience, CAT#471-99) |
| Orexin A, Xenopus SS (4-10/5-12) (Echelon Bioscience, CAT#479-99) |
| Orexin B, human (Echelon Bioscience, CAT#471-98) |
| Oxyntomodulin (Glucagon 1-37) (Echelon Bioscience, CAT#471-33) |
| Oxytocin (Echelon Bioscience, CAT#670-67) |
| p-I-L-Phe4 human beta amyloid (1-40) (Echelon Bioscience, CAT#640-33) |
| P-lysoPC (16:0 LPC) (Echelon Bioscience, CAT#L-1516) |
| PACAP (1-27), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-37) |
| PACAP (1-38), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-35) |
| Palmitoyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0310) |
| Pancreastatin (1-52), human (Echelon Bioscience, CAT#481-20) |
| Pancreatic Elastase Substrate, colorimetric (Echelon Bioscience, CAT#883-18) |
| Pancreatic Leukocyte Elastase Substrate, colorimetric (Echelon Bioscience, CAT#881-15) |
| Pancreatic polypeptide bovine (Echelon Bioscience, CAT#474-21) |
| Pancreatic Polypeptide, avian (Echelon Bioscience, CAT#478-40) |
| PAPEth (16:0/20:4 PEth) (Echelon Bioscience, CAT#L-6024) |
| PAR (1-6) amide [Ala1], Mouse (Echelon Bioscience, CAT#875-28) |
| PAR-1 agonist (Echelon Bioscience, CAT#875-27) |
| PAR-2 (1-6)amide human (Echelon Bioscience, CAT#875-23) |
| Parathyroid Hormone (PTH) (1-34), human (Echelon Bioscience, CAT#231-40) |
| Parathyroid Hormone (PTH) (1-34), rat (Echelon Bioscience, CAT#235-36) |
| Parathyroid Hormone (PTH) (2-34), human (Echelon Bioscience, CAT#231-43) |
| Parathyroid Hormone (PTH) (3-34), human (Echelon Bioscience, CAT#231-46) |
| Parathyroid Hormone (PTH) (39-68), human (Echelon Bioscience, CAT#231-50) |
| Parathyroid Hormone (PTH) (39-84), human (Echelon Bioscience, CAT#231-55) |
| Parathyroid Hormone (PTH) (4-34), human (Echelon Bioscience, CAT#231-48) |
| Parathyroid Hormone (PTH) (5-34), human (Echelon Bioscience, CAT#231-51) |
| Parathyroid Hormone (PTH) (53-84), human (Echelon Bioscience, CAT#231-60) |
| Parathyroid Hormone (PTH) [Nle8,18,Tyr34] (3-34), amide, bovine (Echelon Bioscience, CAT#233-35) |
| Parathyroid Hormone [Nle8,18,Tyr34](1-34) amide, bovine (Echelon Bioscience, CAT#233-32) |
| PC Lipid Microparticles (Echelon Bioscience, CAT#P-B1PC) |
| PC/PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PCPS) |
| PDQ, Antimicrobial Peptide from Xenopus Laevis (Echelon Bioscience, CAT#745-10) |
| Peptide YY, PYY (3-36) , canine , mouse , porcine , rat (Echelon Bioscience, CAT#490-56) |
| Peptide YY, PYY (3-36), human (Echelon Bioscience, CAT#490-11) |
| PF-543 (Sphingosine Kinase I Inhibitor) (Echelon Bioscience, CAT#B-0026) |
| PF-8380 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0702) |
| Phe-Met-Arg-D-Phe-NH2 (Echelon Bioscience, CAT#610-49) |
| Phe-Met-Arg-Phe-NH2 (FMRF Peptide) (Echelon Bioscience, CAT#610-44) |
| Pheromonotropin, Pseudalatia (Echelon Bioscience, CAT#782-10) |
| PHI, rat (Echelon Bioscience, CAT#495-25) |
| Phosphatase Substrate (Echelon Bioscience, CAT#871-70) |
| Phosphatidic Acid (PA) Beads (Echelon Bioscience, CAT#P-B0PA) |
| Phosphatidylcholine (PC) Beads (Echelon Bioscience, CAT#P-B0PC) |
| Phosphatidylethanol (PEth) Beads (Echelon Bioscience, CAT#P-BPETH) |
| Phosphatidylethanol (PEth) ELISA (Echelon Bioscience, CAT#K-5000) |
| Phosphatidylethanolamine (PE) Beads (Echelon Bioscience, CAT#P-B0PE) |
| Phosphatidylinositol 4,5-bisphosphate 18:0/20:4 (Echelon Bioscience, CAT#P-4524) |
| Phosphatidylinositol diC16 (PI diC16) (Echelon Bioscience, CAT#P-0016) |
| Phosphatidylinositol diC4 (PI diC4) (Echelon Bioscience, CAT#P-0004) |
| Phosphatidylinositol diC8 (ammonium salt) (Echelon Bioscience, CAT#P-0008A) |
| Phosphatidylinositol diC8 (PI diC8) (Echelon Bioscience, CAT#P-0008) |
| Phosphatidylserine (PS) Beads (Echelon Bioscience, CAT#P-B0PS) |
| Phospholipase A2 activating peptide (Echelon Bioscience, CAT#495-26) |
| PI PolyPIPosomes (Echelon Bioscience, CAT#Y-P000) |
| PI-103 (PI3-K alpha Inhibitor 1) (Echelon Bioscience, CAT#B-0303) |
| PI(3,4,5)P3 17:0/16:0 (Echelon Bioscience, CAT#P-3917) |
| PI(3,4,5)P3 18:0/20:4 (Echelon Bioscience, CAT#P-3924) |
| PI(3,4,5)P3 diC16 (Echelon Bioscience, CAT#P-3916) |
| PI(3,4,5)P3 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3916A) |
| PI(3,4,5)P3 diC4 (Echelon Bioscience, CAT#P-3904) |
| PI(3,4,5)P3 diC8 (Echelon Bioscience, CAT#P-3908) |
| PI(3,4,5)P3 Grip (Grp1-PH) (Echelon Bioscience, CAT#G-3901) |
| PI(3,4,5)P3 PIP Beads (Echelon Bioscience, CAT#P-B345A) |
| PI(3,4,5)P3 PolyPIPosomes (Echelon Bioscience, CAT#Y-P039) |
| PI(3,4)P2 diC16 (Echelon Bioscience, CAT#P-3416) |
| PI(3,4)P2 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3416A) |
| PI(3,4)P2 diC4 (Echelon Bioscience, CAT#P-3404) |
| PI(3,4)P2 diC8 (Echelon Bioscience, CAT#P-3408) |
| PI(3,4)P2 Mass ELISA (Echelon Bioscience, CAT#K-3800) |
| PI(3,4)P2 PIP Beads (Echelon Bioscience, CAT#P-B034A) |
| PI(3,4)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P034) |
| PI(3,5)P2 diC16 (Echelon Bioscience, CAT#P-3516) |
| PI(3,5)P2 diC4 (Echelon Bioscience, CAT#P-3504) |
| PI(3,5)P2 diC8 (Echelon Bioscience, CAT#P-3508) |
| PI(3,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B035A) |
| PI(3,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P035) |
| PI(3)P diC16 (Echelon Bioscience, CAT#P-3016) |
| PI(3)P diC4 (Echelon Bioscience, CAT#P-3004) |
| PI(3)P diC8 (Echelon Bioscience, CAT#P-3008) |
| PI(3)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-3008A) |
| PI(3)P Grip (p40 PX) (Echelon Bioscience, CAT#G-0302) |
| PI(3)P Mass ELISA (Echelon Bioscience, CAT#K-3300) |
| PI(3)P PIP Beads (Echelon Bioscience, CAT#P-B003A) |
| PI(3)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P003) |
| PI(4,5)P2 diC16 (Echelon Bioscience, CAT#P-4516) |
| PI(4,5)P2 diC4 (Echelon Bioscience, CAT#P-4504) |
| PI(4,5)P2 diC8 (Echelon Bioscience, CAT#P-4508) |
| PI(4,5)P2 Grip (PLC-d1-PH) (Echelon Bioscience, CAT#G-4501) |
| PI(4,5)P2 Mass ELISA Kit (Echelon Bioscience, CAT#K-4500) |
| PI(4,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B045A) |
| PI(4,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P045) |
| PI(4)P 5-Kinase (PIP5KI) Activity Assay (Echelon Bioscience, CAT#K-5700) |
| PI(4)P diC16 (Echelon Bioscience, CAT#P-4016) |
| PI(4)P diC4 (Echelon Bioscience, CAT#P-4004) |
| PI(4)P diC8 (Echelon Bioscience, CAT#P-4008) |
| PI(4)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-4008A) |
| PI(4)P Grip (SidC-3C) (Echelon Bioscience, CAT#G-0402) |
| PI(4)P Mass ELISA Kit (Echelon Bioscience, CAT#K-4000E) |
| PI(4)P PIP Beads (Echelon Bioscience, CAT#P-B004A) |
| PI(4)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P004) |
| PI(5)P 4-Kinase (PIP4KII) Activity Assay (Echelon Bioscience, CAT#K-5400) |
| PI(5)P diC16 (Echelon Bioscience, CAT#P-5016) |
| PI(5)P diC4 (Echelon Bioscience, CAT#P-5004) |
| PI(5)P diC8 (Echelon Bioscience, CAT#P-5008) |
| PI(5)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-5008A) |
| PI(5)P PIP Beads (Echelon Bioscience, CAT#P-B005A) |
| PI(5)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P005) |
| PI3-K alpha Inhibitor 2 (Echelon Bioscience, CAT#B-0304) |
| PI3-K Alpha Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300A) |
| PI3-K Beta Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300B) |
| PI3-Kinase Activity AlphaScreen Assay (Echelon Bioscience, CAT#K-1300) |
| PI3-Kinase Activity ELISA: Pico (Echelon Bioscience, CAT#K-1000S) |
| PI3-Kinase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1100) |
| PI3-Kinase alpha (PI3Ka), active (Echelon Bioscience, CAT#E-2000) |
| PI3K (p110alpha/p85alpha), active (Echelon Bioscience, CAT#P27-18H) |
| PI3K (p110beta/p85alpha), active (Echelon Bioscience, CAT#P28-102H) |
| PI3Ka, E545K – Active Mutant (Echelon Bioscience, CAT#P27-15H) |
| PI4-Kinase Activity Assay (Echelon Bioscience, CAT#K-4000K) |
| PI4-Kinase beta (PI4Kb), active (Echelon Bioscience, CAT#P32-102G) |
| PI4-Kinase II alpha (PI4KIIa), active (Echelon Bioscience, CAT#P21-10G) |
| PI4-Kinase II beta (PI4KIIb), active (Echelon Bioscience, CAT#P22-10G) |
| PIK-93 (PI4KIIIb inhibitor) (Echelon Bioscience, CAT#B-0306) |
| PIP Array – Lipid-Protein Interaction Assay (Echelon Bioscience, CAT#P-6100) |
| PIP Beads Sample Pack (Echelon Bioscience, CAT#P-B00S) |
| PIP Pack (Echelon Bioscience, CAT#P-P100) |
| PIP Strips (Echelon Bioscience, CAT#P-6001) |
| PIP3 Mass ELISA Kit (Echelon Bioscience, CAT#K-2500S) |
| PKA Inhibitor (Echelon Bioscience, CAT#867-10) |
| PKA Substrate (Echelon Bioscience, CAT#866-25) |
| PKC Isoenzyme Inhibitor (myristoylated) (Echelon Bioscience, CAT#880-17) |
| PKC Isoenzyme Inhibitor / PKC Y translocation peptide (Echelon Bioscience, CAT#880-15) |
| PKC(e) Translocation Inhibitor – negative control (Echelon Bioscience, CAT#880-69) |
| PKG Substrate, Glasstide, H2Btide (Echelon Bioscience, CAT#870-74) |
| PKI (5-24), PKA Inhbibitor (Echelon Bioscience, CAT#890-98) |
| Plasmepsin II substrate (Echelon Bioscience, CAT#871-13) |
| PLPC (16:0/12:0 PC) (Echelon Bioscience, CAT#L-1612) |
| PLPC (16:0/18:2 PC) (Echelon Bioscience, CAT#L-1122) |
| PLPEth (16:0/18:2 PEth) (Echelon Bioscience, CAT#L-6020) |
| Pneumadin, rat (Echelon Bioscience, CAT#675-85) |
| PNPP Substrate & Solution (Echelon Bioscience, CAT#K-1208T) |
| Poly-Selective Phosphoinositide Phosphate Antibody (Echelon Bioscience, CAT#Z-P999) |
| POPC (16:0/18:1 PC) (Echelon Bioscience, CAT#L-1618) |
| POPEth (16:0/18:1 PEth) (Echelon Bioscience, CAT#L-6019) |
| Porphobilinogen (Echelon Bioscience, CAT#F-H020) |
| PPlases Substare, fluorogenic (Echelon Bioscience, CAT#869-20) |
| PPLases Substrate, colorimetric (Echelon Bioscience, CAT#869-10) |
| ProAM N20, human / Proadrenomedullin N-term 20 Peptide, huma (Echelon Bioscience, CAT#331-81) |
| ProAM N20, rat / Proadrenomedullin N terminal 20 peptide, rat (Echelon Bioscience, CAT#335-81) |
| Prodynorphin 228-256 (porcine) (Dynorphin B 29, Leumorphin) (Echelon Bioscience, CAT#274-56) |
| Propargyl-farnesol (Echelon Bioscience, CAT#S-0160) |
| Propargyl-geraniol (Echelon Bioscience, CAT#S-0110) |
| Prostate Specific Antigen Substrate (Echelon Bioscience, CAT#891-15) |
| Prot. Kin. C Pseudosubstrate Inhibitor (Echelon Bioscience, CAT#890-91) |
| Protein Kinase C (19-31), Protein Kinase C pseudosubstrate, (Echelon Bioscience, CAT#871-20) |
| Protein Kinase C Substrate (Echelon Bioscience, CAT#890-82) |
| Protein Kinase C substrate from EGF Receptor (Echelon Bioscience, CAT#871-55) |
| Protein Kinase Inhibitor Cdk2 (Echelon Bioscience, CAT#871-87) |
| Protein Tyrosine Phosphatase Substrate, fluorogenic (Echelon Bioscience, CAT#871-62) |
| Protoporphyrin IX (Echelon Bioscience, CAT#F-H050) |
| PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PS) |
| PS48 (PDK1 Activator) (Echelon Bioscience, CAT#B-0360) |
| PtdIns PIP Beads (Echelon Bioscience, CAT#P-B001) |
| PtdIns(4,5)P2 a-fluorovinylphosphate diC8 (Echelon Bioscience, CAT#P-FV4508) |
| PTEN Activity ELISA Kit (Echelon Bioscience, CAT#K-4700) |
| PTEN Enzyme, active (Echelon Bioscience, CAT#E-3000) |
| PTH Related Peptide (7-34) amide, human (Echelon Bioscience, CAT#231-94) |
| PTH Related Peptide [Asn10,Leu11] (7-34) amide, human (Echelon Bioscience, CAT#231-95) |
| PTH Related Peptide [Leu11, DTrp12] (7-34) amide, human (Echelon Bioscience, CAT#231-96) |
| PTH Related protein (1-40); Hypercalcemia Malignancy Factor (Echelon Bioscience, CAT#231-85) |
| Purified Anti-LPLA2 Antibody (Echelon Bioscience, CAT#Z-PLPLA2) |
| Purified Anti-Phosphatidylethanol Antibody (Echelon Bioscience, CAT#Z-PETH) |
| Purified Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-P345B) |
| Purified Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-P345) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034B) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034) |
| Purified Anti-PtdIns(3,5)P2 IgG (Echelon Bioscience, CAT#Z-P035) |
| Purified Anti-PtdIns(3)P IgG (Echelon Bioscience, CAT#Z-P003) |
| Purified Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-P045) |
| Purified Anti-PtdIns(4)P IgM (Echelon Bioscience, CAT#Z-P004) |
| Purified Mouse Anti-LBPA (BMP) (Echelon Bioscience, CAT#Z-PLBPA) |
| Rabbit Anti-Human DGK Zeta Antibody (Echelon Bioscience, CAT#Z-DGKZ) |
| Ranakinin, frog (Echelon Bioscience, CAT#361-50) |
| Renin Substrate I (Echelon Bioscience, CAT#131-20) |
| Resveratrol (Echelon Bioscience, CAT#B-0021) |
| Rha(rac)C10C10 (Echelon Bioscience, CAT#RL10105) |
| Rha(rac)C12C12 (Echelon Bioscience, CAT#RL12125) |
| RR-SRC, Insulin receptor kinase substrate (Echelon Bioscience, CAT#870-68) |
| S-lysoPC, (18:0 LPC) (Echelon Bioscience, CAT#L-1518) |
| S1P Beads (Echelon Bioscience, CAT#S-6110) |
| S1P Fluorescein (Echelon Bioscience, CAT#S-200F) |
| S1P Lyase Fluorogenic Substrate (Echelon Bioscience, CAT#S-200U) |
| S1P TAMRA (Echelon Bioscience, CAT#S-200T) |
| S32826 [4-(Tetradecanoylamino)benzyl]phosphonic acid disodium salt] (Echelon Bioscience, CAT#L-3282) |
| S6 Phosphate Acceptor Peptide (Echelon Bioscience, CAT#890-72) |
| Sarafotoxin 6b (Echelon Bioscience, CAT#339-10) |
| Sarilesin – Angiotensin II [Sar1,Ile8] (Echelon Bioscience, CAT#131-63) |
| Sauvagine, frog (Echelon Bioscience, CAT#357-26) |
| SDT1 (Pyrimidine 5′-nucleotidase) (Echelon Bioscience, CAT#E-20SDT1) |
| Select-HA 1000k (Echelon Bioscience, CAT#HYA-1000KEF-1) |
| Select-HA 500k (Echelon Bioscience, CAT#HYA-500KEF-1) |
| Select-HA 50k (Echelon Bioscience, CAT#HYA-50KEF-1) |
| Select-HA 601k (Echelon Bioscience, CAT#HYA-601KEF-1) |
| Select-HA HiLadder (Echelon Bioscience, CAT#HYA-HILAD-20) |
| Select-HA LoLadder (Echelon Bioscience, CAT#HYA-LOLAD-20) |
| Senktide ;Substance P [Suc-,Asp6,Me-Phe8] (6-11) (Echelon Bioscience, CAT#712-14) |
| SF1670 (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0350) |
| Sheep Anti-Human DGK Alpha Peptide Antibody (Echelon Bioscience, CAT#Z-DGKA) |
| SHIP2 Lipid Phosphatase Enzyme, active (Echelon Bioscience, CAT#E-1000) |
| SHIP2 Reaction Buffer (Echelon Bioscience, CAT#K-S2RB) |
| Shuttle PIP Kit, PtdIns(3,4,5)P3 (Echelon Bioscience, CAT#P-9039) |
| Shuttle PIP Kit, PtdIns(3,4)P2 (Echelon Bioscience, CAT#P-9034) |
| Shuttle PIP Kit, PtdIns(3,5)P2 (Echelon Bioscience, CAT#P-9035) |
| Shuttle PIP Kit, PtdIns(3)P (Echelon Bioscience, CAT#P-9003) |
| Shuttle PIP Kit, PtdIns(4,5)P2 (Echelon Bioscience, CAT#P-9045) |
| Shuttle PIP Kit, PtdIns(4)P (Echelon Bioscience, CAT#P-9004) |
| Shuttle PIP Kit, PtdIns(5)P (Echelon Bioscience, CAT#P-9005) |
| SKI-178 (SPHK1 Inhibitor) (Echelon Bioscience, CAT#B-0028) |
| SLPEth (18:0/18:2 PEth) (Echelon Bioscience, CAT#L-6022) |
| SMPC (18:0/14:0 PC) (Echelon Bioscience, CAT#L-1814) |
| sn-1-Fluorescein-labeled Cardiolipin (Echelon Bioscience, CAT#L-C16F) |
| Sn(IV) Protoporphyrin IX, 14325-05-4 (Echelon Bioscience, CAT#F-H080) |
| SNP-1 (Echelon Bioscience, CAT#888-10) |
| Somatostatin 28 (1-12) (Echelon Bioscience, CAT#691-77) |
| Somatostatin 28, cyclic (Echelon Bioscience, CAT#691-65) |
| Somatostatin Antagonist, cyclic / Coy (Echelon Bioscience, CAT#691-63) |
| Somatostatin, cyclic (Echelon Bioscience, CAT#691-25) |
| SOPEth (18:0/18:1 PEth) (Echelon Bioscience, CAT#L-6021) |
| Sorbitan monostearate (Echelon Bioscience, CAT#R-1318) |
| Spantide ([D-Arg1,D-Trp7,9,Substance P Leu11] (Echelon Bioscience, CAT#712-31) |
| Spantide II (Echelon Bioscience, CAT#712-36) |
| Specific NFAT Inhibitor / VIVIT-16 (Echelon Bioscience, CAT#887-16) |
| Sperm Activating Peptide, Sea Urchin (Echelon Bioscience, CAT#610-52) |
| Sphinganine-biotin (Echelon Bioscience, CAT#S-110B) |
| Sphinganine-fluorescein (Echelon Bioscience, CAT#S-110F) |
| Sphingo Arrays (Echelon Bioscience, CAT#S-6001) |
| Sphingo Beads (Echelon Bioscience, CAT#S-6100) |
| Sphingo Beads Sample Pack (Echelon Bioscience, CAT#P-B00SS) |
| Sphingo Strips (Echelon Bioscience, CAT#S-6000) |
| Sphingomyelin Beads (Echelon Bioscience, CAT#P-B0SM) |
| Sphingosine 1-Phosphate (S1P) (Echelon Bioscience, CAT#S-2000) |
| Sphingosine 1-Phosphate Antibody (Echelon Bioscience, CAT#Z-P300) |
| Sphingosine 1-Phosphate Assay Service (Echelon Bioscience, CAT#T-1900) |
| Sphingosine 1-phosphate biotin (S1P-biotin) (Echelon Bioscience, CAT#S-200B) |
| Sphingosine 1-Phosphate ELISA Kit (Echelon Bioscience, CAT#K-1900) |
| Sphingosine 1-Phosphate Lyase Overexpression Lysate, active (Echelon Bioscience, CAT#E-5000L) |
| Sphingosine 1-Phosphate Lyase, active (Echelon Bioscience, CAT#E-5000P) |
| Sphingosine kinase 1, active (Echelon Bioscience, CAT#E-K068) |
| Sphingosine kinase 2, active (Echelon Bioscience, CAT#E-K069) |
| Sphingosine Kinase Activity Assay (Echelon Bioscience, CAT#K-3500) |
| Sphingosine Kinase Inhibitor (SKI-II) (Echelon Bioscience, CAT#B-0024) |
| Sphingosine-biotin (Echelon Bioscience, CAT#S-100B) |
| Sphingosine-fluorescein (Echelon Bioscience, CAT#S-100F) |
| Sphingosine-tetramethylrhodamine (Echelon Bioscience, CAT#S-100T) |
| Squalene, purified (Echelon Bioscience, CAT#S-0300) |
| SS14 Tumor Inhibitor Analog (Echelon Bioscience, CAT#691-60) |
| Stercobilin Hydrochloride (Echelon Bioscience, CAT#F-H150) |
| Substance P (Echelon Bioscience, CAT#711-25) |
| Substance P (5-11) / Hepta-Substance P (Echelon Bioscience, CAT#711-66) |
| Substance P [Nle11] (Echelon Bioscience, CAT#711-36) |
| Substance P [Sar9] (Echelon Bioscience, CAT#711-48) |
| Substance P [Tyr8] (Echelon Bioscience, CAT#711-33) |
| Substance P, (p-Cl-Phe7,8) (Echelon Bioscience, CAT#712-55) |
| Substrate for E. Coli Leader Peptidase (Echelon Bioscience, CAT#887-10) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-77) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-78) |
| Suc-Ala-Ala-Ala-Ala-pNA (Echelon Bioscience, CAT#876-02) |
| Suc-Ala-Ala-Leu-pNA (Echelon Bioscience, CAT#876-03) |
| Suc-Ala-Ala-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-32) |
| Suc-Ala-Ala-Pro-Phe-AFC (Pancreatic Elastase Substrate (human), fluorogenic) (Echelon Bioscience, CAT#881-34) |
| Suc-Ala-Ala-Pro-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-31) |
| Suc-Ala-Ala-Pro-Phe-pNA (Pancreatic Leukocyte Elastase (human) Substrate, colorimetric) (Echelon Bioscience, CAT#881-30) |
| Suc-Gly-Gly-Phe-pNA (Chymotrypsin Substrate , colorimetric) (Echelon Bioscience, CAT#881-33) |
| Suc-Leu-Leu-Val-Tyr-AFC (Chymotrypsin like Enzyme Substrate, fluorogenic) (Echelon Bioscience, CAT#881-21) |
| Suc-Leu-Leu-Val-Tyr-AMC (Proteosome Substrate) (Echelon Bioscience, CAT#881-18) |
| Suc-Leu-Tyr-4-methoxy-2-naphthylamide (Calpain I & II, Papain Substrate, fluorogenic) (Echelon Bioscience, CAT#878-01) |
| Suc-Phe-Ala-His-Phe-AMC (Echelon Bioscience, CAT#877-10) |
| Suc-Phe-Ala-His-Phe-pNA (Echelon Bioscience, CAT#876-04) |
| Synthetic 16:0 Cardiolipin (Echelon Bioscience, CAT#L-C160) |
| Synthetic 16:0 Monolysocardiolipin (Echelon Bioscience, CAT#L-M160) |
| Syntide 2, CaMKII Substrate (Echelon Bioscience, CAT#105-77) |
| TACE Substrate (Fluorogenic) (Echelon Bioscience, CAT#860-78) |
| Thio-ccPA (Echelon Bioscience, CAT#L-7118) |
| Thrombin , Trypsin , Papain Substrate (Echelon Bioscience, CAT#920-13) |
| Thrombin Receptor Activator Peptide 6 / TRAP-6 (Echelon Bioscience, CAT#920-51) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-29) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-53) |
| Thrombin Receptor Agonist; (Echelon Bioscience, CAT#920-52) |
| Thrombin Receptor Antagonist (Echelon Bioscience, CAT#920-50) |
| Thymosin b4 (1-4) (Echelon Bioscience, CAT#885-21) |
| TMB Precipitating (Echelon Bioscience, CAT#K-TMBP) |
| TMR Labeled Carrier 1 (Neomycin B Sulfate) (Echelon Bioscience, CAT#P-9C1R) |
| TMR Labeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2R) |
| TNF coverting enzyme substrate (Echelon Bioscience, CAT#882-50) |
| Trismethoxyresveratrol (Echelon Bioscience, CAT#B-0022) |
| Tyr(PO3H2)4 Angiotensin II, human (Echelon Bioscience, CAT#131-48) |
| Tyrosine Specific Protein Kinase Inhibitor Peptide A (Echelon Bioscience, CAT#890-88) |
| Unlabeled Shuttle PIP Carrier 1 (Echelon Bioscience, CAT#P-9C1) |
| Unlabeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2) |
| Unlabeled Shuttle PIP Carrier 3 (Echelon Bioscience, CAT#P-9C3) |
| Uridine Diphosphate-Bodipy-FL (UDP-Bodipy-FL) (Echelon Bioscience, CAT#N-100F) |
| Urobilin Hydrochloride (Echelon Bioscience, CAT#F-H140) |
| Urocortin, human (Echelon Bioscience, CAT#353-10) |
| Urocortin, rat (Echelon Bioscience, CAT#353-20) |
| Urodilatin (Echelon Bioscience, CAT#151-30) |
| Uroporphyrin I dihydrochloride (Echelon Bioscience, CAT#F-H040) |
| Uroporphyrin III dihydrochloride (Echelon Bioscience, CAT#F-H030) |
| Urotensin I, carp (Echelon Bioscience, CAT#817-40) |
| Urotensin I, suckerfish (Echelon Bioscience, CAT#817-30) |
| Urotensin II, human (Echelon Bioscience, CAT#817-50) |
| Vasoactiv Intestinal Peptide [Lys1,Pro2,5,Arg3,4,Tyr6] / VI (Echelon Bioscience, CAT#491-32) |
| Vasoactive Intestinal Constrictor / Mouse Beta Endothelin / (Echelon Bioscience, CAT#337-10) |
| Vasoactive Intestinal Peptide (6-28),human, porcine, rat / V (Echelon Bioscience, CAT#491-29) |
| Vasoactive Intestinal Peptide / VIP, human, porcine, rat (Echelon Bioscience, CAT#491-25) |
| Vasopressin ( Pmp1,Tyr(Et)2,Val4,Arg8 ) cyclic (Echelon Bioscience, CAT#670-32) |
| Vasopressin [Arg8] (AVP), cyclic (Echelon Bioscience, CAT#670-18) |
| Vasopressin [Deamino-Pen1,Val4,D-Arg8] (Echelon Bioscience, CAT#670-36) |
| Vasopressin [Lys-8] (Echelon Bioscience, CAT#670-17) |
| Vasopressin [Pmp1, Tyr(0Me)2, Arg8] (Echelon Bioscience, CAT#670-24) |
| Vasotocin [Arg8] cyclic (Echelon Bioscience, CAT#670-65) |
| Versican G1 Domain (Echelon Bioscience, CAT#G-HA01) |
| VIP Antagonist [Ac-Tyr1,D-Phe2]-GRF(1-29)NH2 (Echelon Bioscience, CAT#491-41) |
| VO-OHpic (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0351) |
| VPC 23019 (S1P1/3 Antagonist) (Echelon Bioscience, CAT#B-0061) |
| Whole-Cell MEP Pathway-Selective Antibacterial Screening Assay Service (Echelon Bioscience, CAT#T-2000) |
| Wortmannin (Echelon Bioscience, CAT#B-0222) |
| XY-14 (Lipid Phosphate Phosphatase 1 Inhibitor) (Echelon Bioscience, CAT#L-9218) |
| XY-17 (LPA3 Agonist) (Echelon Bioscience, CAT#L-9118) |
| XY-4 (LPA analog) (Echelon Bioscience, CAT#L-1160) |
| Z-Ala-Ala-Asp-AFC (Cathepsin S Substrate, fluorogenic) (Echelon Bioscience, CAT#874-06) |
| Z-Ala-Arg-Arg-MbNA (Cathepsin B Substrate II, fluorogenic) (Echelon Bioscience, CAT#866-29) |
| Z-Ala-Lys-Arg-AMC (Echelon Bioscience, CAT#877-03) |
| Z-Arg-Arg-AMC (Cathepsin B substrate, fluorogenic) (Echelon Bioscience, CAT#866-30) |
| Z-Arg-Arg-MbNA (Cathepsin B Substrate, fluorogenic) (Echelon Bioscience, CAT#866-31) |
| Z-Arg-Arg-pNA (Cathepsin B substrate, colorimetric) (Echelon Bioscience, CAT#866-27) |
| Z-Asp-Glu-Val-Asp-AFC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-18) |
| Z-Asp-Glu-Val-Asp-pNA (Caspase 3 (Apopain) substrate) (Echelon Bioscience, CAT#861-20) |
| Z-Glu-Ala-Asp-CHO (Echelon Bioscience, CAT#878-05) |
| Z-Gly-Gly-Arg-AMC (Urokinase Substrate III, fluorogenic) (Echelon Bioscience, CAT#869-25) |
| Z-Gly-Gly-Leu-AMC (Proteasome Substrate, fluorogenic) (Echelon Bioscience, CAT#882-31) |
| Z-Gly-Val-Val-AMC (Echelon Bioscience, CAT#877-04) |
| Z-Ile-Glu-Thr-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-56) |
| Z-Ile-Glu-Thr-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#863-61) |
| Z-Leu-Arg-AMC (Cathepsin, Kallikrein, Falcipain II substrate, fluorogenic) (Echelon Bioscience, CAT#877-14) |
| Z-Leu-Leu-Glu-AMC (Proteasome Substrate 2, fluorogenic) (Echelon Bioscience, CAT#882-21) |
| Z-Leu-Leu-Leu-AMC (Proteasome Substrate 1, fluorogenic) (Echelon Bioscience, CAT#882-20) |
| Z-Leu-Leu-Phe-CHO (Proteasome Inhibitor 2) (Echelon Bioscience, CAT#882-12) |
| Z-Phe-Ala-pNA (Echelon Bioscience, CAT#876-05) |
| Z-Phe-Arg-AFC (Cathepsin L Substrate, fluorogenic) (Echelon Bioscience, CAT#866-75) |
| Z-Phe-Arg-AMC (Kallikrein substrate) (Echelon Bioscience, CAT#871-75) |
| Z-Phe-CHO (Echelon Bioscience, CAT#878-06) |
| Z-Phe-Tyr-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-28) |
| Z-Tyr-Val-Ala-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-17) |
| Z-Tyr-Val-Ala-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-28) |
| Z-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-49) |
| Z-Val-Gly-Arg-pNA (Urokinase Substrate I, colorimetric) (Echelon Bioscience, CAT#869-31) |
| Z-Val-Ile-Ala-AMC (IRCM Serine Protease I Substrate, fluorogenic) (Echelon Bioscience, CAT#877-05) |
| Z-Val-Lys-Met-AMC (Proteasome Substrate 4, fluorogenic) (Echelon Bioscience, CAT#882-23) |
| Z-Val-Phe-CHO (Calpain Inhibitor III) (Echelon Bioscience, CAT#870-50) |
| Z-Val-Pro-Arg-pNA (Echelon Bioscience, CAT#876-08) |
| Z-Val-Val-Arg-AFC (Echelon Bioscience, CAT#874-01) |
| Zn (II) Deuteroporphyrin IX 2,4 bisethylene glycol (Echelon Bioscience, CAT#F-H090) |
| Zn Protoporphyrin IX (Echelon Bioscience, CAT#F-H060) |
| ZSTK474 (PI3K Inhibitor) (Echelon Bioscience, CAT#B-0307) |
更多详情请联系
艾美捷科技有限公司
全国服务热线：400-6800-868
邮箱：sales@amyjet.com
网站：www.amyjet.com
" data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Echelon Biosciences"> Echelon Biosciences
艾美捷科技代理Polysciences品牌。
Polysciences的产品以其高质量和多样性而著称，特别是在聚乙烯亚胺（Polyethylenimine，PEI）转染试剂方面有着显著的优势。Polysciences公司成立于1961年，主要生产和经营生命科学（胶体金、不含甲醛的甲醇等）、病理学和显镜学微球和粒子、磁珠、各种单体和聚体等产品；作为世界上最大最全的多聚化合物供应商，同时也是世界领先的免疫学、组织化学试剂耗材供应商。
Polysciences特色的PEI转染试剂特点包括：
（1）高效性：PEI转染试剂具有高效的瞬转效率和蛋白产量，广泛应用于基因和细胞治疗产品的开发，包括病毒载体和蛋白质工艺开发、临床试验以及商业化生产。
（2）广泛适用性：适用于多种细胞系，如HEK293、CHO、Sf9等，且转染效率高达80%~90%。
（3）升级产品：如PEI MAX 40K，作为第一代PEI 25K的升级产品，其去乙酰化和盐酸盐形式增强了水溶性，提高了转染效率。
产品应用范围包括：
病毒载体开发：可用于生产和优化病毒载体，将基因修饰的病毒载体导入目标细胞内，从而实现基因转染；
重组蛋白表达：可以将编码目标蛋白的基因高效地转入宿主细胞，从而大量表达所需的重组蛋白；
基因编辑技术：如CRISPR-Cas9系统中，PEI转染试剂用于将相关基因编辑组件送入细胞内；
细胞治疗研究：用于提高细胞的治疗效果和生存率，需要将特定的遗传物质传递到细胞内，以改变细胞的行为或增强其治疗效果。
<<<< " data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理Polysciences品牌转染试剂"> 艾美捷科技代理Polysciences品牌转染试剂
艾美捷科技代理Ligatrap品牌全系列产品
LigaTrap Technologies是一家位于北卡罗来纳州的创新型生物技术公司，提供独特的专利技术组合，专注于蛋白质纯化领域。LigaTrap精于抗体与病毒纯化，服务于抗体药物、病毒疫苗及基因治疗产业。
▍LigaTrap公司产品
● LigaGuard：最新推出的亲和吸附剂，是由多模态配体构成的专利复合体系，可在流穿模式（连续流）下选择性捕获宿主细胞蛋白（HCPs）与DNA。
● AAVidity™：一种新型亲和层析填料，用于血清型普适性纯化 源自 HEK293 和 Sf9 细胞裂解液 的 腺相关病毒（AAV）。
● IgM Resin：专为纯化 IgM 抗体设计的亲和树脂，具有高纯度、高结合能力、温和的洗脱条件（pH 约 4.0），并可重复使用多达 100 次。
● Base Resin：专为从多克隆与单克隆来源中纯化高质量抗体而设计，该树脂推荐用于纯化：多种物种的 IgG（包括人、小鼠、兔等）；人源 IgA；鸡源 IgY。
● LigaTrap Buffers：包含Regeneration Buffer，Neutralization Buffer，Elution Buffer，Regeneration Buffer，Equilibration/Wash Buffer 2.0等。
▍LigaGuard
LigaGuard™树脂适用于两类核心产品的纯化：蛋白制品：单克隆抗体、生长因子；病毒制品：慢病毒、腺相关病毒（AAV）、病毒疫苗。该树脂的设计使目标生物产物无结合通过，实现高纯度与高回收率。其能清除传统纯化工艺难以去除的高残留性HCPs（HR-HCPs），显著提升终产物的纯度、稳定性、疗效与安全性。
| 品名 | 货号 | 规格 |
| LigaTrap LigaGuard 1 ml Packed Column | LT-LG1-1x1mL | 1mL |
| LigaTrap LigaGuard 5ml Packed Column | LT-LG1-1x5mL | 5mL |
| LigaTrap LigaGuard Loose Resin - 5mL | LT-LG1 | 5 mL |
| LigaTrap LigaGuard Loose Resin - 10mL | LT-LG1-10mL | 10 mL |
| LigaTrap LigaGuard Loose Resin - 25mL | LT-LG1-25mL | 25 mL |
| LigaTrap LigaGuard Loose Resin - 50mL | LT-LG1-50mL | 50 mL |
| LigaTrap LigaGuard Loose Resin - 100mL | LT-LG1-100mL | 100 mL |
▍AAVidity
AAVidity填料通过合成亲和配体功能化修饰，可捕获所有血清型的 AAV，提供卓越的结合载量与污染物（宿主细胞蛋白 HCPs 及宿主细胞DNA hcDNA清除能力。其温和洗脱条件在保障 AAV 转导活性的同时，实现高产物回收率。
| 品名 | 货号 | 规格 |
| LigaTrap AAVidity Loose Resin – 1mL | LT-AAV-1mL | 1mL |
| LigaTrap AAVidity Loose Resin – 5mL | LT-AAV-5mL | 5mL |
| LigaTrap AAVidity Prepacked Column – 1mL | LT-AAV-1x1mL | 1x1mL |
| LigaTrap AAVidity Prepacked Column – 5mL | LT-AAV-1x5mL | 1x5mL |
▍IgM Resin
IgM纯化树脂的核心优势包括：
● 全面捕获：同时结合IgM的重链与轻链亚型；
● 零风险：无免疫原性及配体脱落；
● 活性保全：温和洗脱条件保障抗体完整性；
● 经济耐用：消毒再生后可重复使用 ≥100 次；
● 该树脂能高效处理并纯化来自以下样本的单克隆 IgM：细胞培养上清，腹水，杂交瘤，其他重组 IgM 来源。
| 品名 | 货号 | 规格 |
| IgM Microspin Column Kit w/ Buffers | LT-155KIT | KIT-10x0.1mL |
| IgM 1mL Prepacked Column Kit w/ Buffers | LT-155-1mL KIT | KIT-1x1mL |
| IgM 5mL Prepacked Column Kit w/ Buffers | LT-155-5mL KIT | KIT-1x5mL |
| IgM Loose Resin – 5mL | LT-155 | 5mL |
| IgM Loose Resin – 10mL | LT-155-10mL | 10mL |
| IgM Loose Resin – 25mL | LT-155-25mL | 25mL |
| IgM Loose Resin – 50mL | LT-155-50mL | 50mL |
| IgM Loose Resin – 100mL | LT-155-100mL | 100mL |
| IgM Microspin Columns without Buffers | LT-155-MSC | 10x0.1mL |
| IgM Prepacked Column – 1mL | LT-155-1x1mL | 1x1mL |
| IgM Prepacked Column – 5mL | LT-155-1x5mL | 1x5mL |
| IgM Prepacked Columns – 3x1mL | LT-155-3x1mL | 3x1mL |
▍Base Resin
LigaTrap基础纯化树脂可实现高回收率与>95%的纯度，而传统Protein A和Protein G填料的回收率甚至低于检测限。通过优化工艺，该树脂的纯度可进一步提升至99%。
| 品名 | 货号 | 规格 |
| Base Resin Microspin Column Kit w/ Buffers | LT-150KIT | KIT-10x0.1mL |
| Base Resin 1mL Prepacked Column Kit w/ Buffers | LT-150-1mL KIT | KIT-1x1mL |
| Base Resin 5mL Prepacked Column Kit w/ Buffers | LT-150-5mL KIT | KIT-1x5mL |
| Loose Base Resin – 5mL | LT-150 | 5mL |
| Loose Base Resin – 10mL | LT-150-10mL | 10mL |
| Loose Base Resin – 25mL | LT-150-25mL | 25mL |
| Loose Base Resin – 50mL | LT-150-50mL | 50mL |
| Loose Base Resin – 100mL | LT-150-100mL | 100mL |
| Base Resin Microspin Columns without Buffers | LT-150-MSC | 10x0.1mL |
| Base Resin Prepacked Column – 1mL | LT-150-1x1mL | 1x1mL |
| Base Resin Prepacked Column – 5mL | LT-150-1x5mL | 1x5mL |
| Base Resin Prepacked Columns – 3x1mL | LT-150-3x1mL | 3x1mL |
▍Buffers
| 品名 | 货号 | 规格 |
| LigaTrap Elution Buffer | BU-123-FP | 125ml |
| LigaTrap Regeneration Buffer | BU-124-FP | 50ml |
| LigaTrap Neutralization Buffer | BU-125-FP | 15ml |
| LigaTrap Storage Buffer | BU-126-FP | 50 ml |
| LigaTrap Sample Diluent 2.0 | BU-131-FP | 15 ml |
| LigaTrap Equilibration/Wash Buffer 2.0 | BU-132-FP | 250ml |
| LigaTrap IgM Elution Buffer pH 3.8 | BU-133-FP | 125 ml |
| LigaTrap Elution Buffer | BU-123-500-FP | 500ml |
| LigaTrap Regeneration Buffer | BU-124-500-FP | 500 ml |
| LigaTrap Neutralization Buffer | BU-125-250-FP | 250 ml |
| LigaTrap Storage Buffer | BU-126-500-FP | 500 ml |
| LigaTrap Sample Diluent 2.0 | BU-131-250-FP | 250 ml |
| LigaTrap Equilibration/Wash Buffer 2.0 | BU-132-1-FP | 1L |
| LigaTrap IgM Elution Buffer pH 3.8 | BU-133-500-FP | 500ml |
艾美捷科技代理Exocell品牌。
Exocell公司是一家专注于糖尿病及其并发症研究相关的产品与服务的生物制品公司。Exocell公司由Margo Cohen于1988年创立，致力于开发与糖尿病及其并发症相关的诊断产品。随着公司的不断发展，Exocell迅速成为该领域的重要供应商，拥有15项专利和2000多项研究引用。目前，Exocell产品已成为Ethos Biosciences（Ott Scientific的一部分）的一部分，继续为全球的学术、生物技术和制药研究团队提供服务。
Exocell产品与服务包括：
（1）临床诊断产品：
Albuwell：用于检测微白蛋白尿，是早期糖尿病性肾功能紊乱的明确标志物。
Creatinine：用于检测尿中的肌酐。
Glycaben：用于监测糖化白蛋白（中期的控糖指标）。
Glycacor：用于检测糖化LDL（短期控糖指标及心血管疾病风险指标）。
Hemoglobin A1c参照标准：长期控糖指标。
（2）临床研发类检测试剂与试剂盒：
Apo B Test：用于检测人血浆中的apolipoprotein B。
Collagen IV H：用于检测样本中的IV型胶原。
hFibronectin ELISA试剂盒：用于检测人血浆中的fibronectin。
Nephrin ELISA试剂盒：用于检测尿液中的nephrin等。
（3）实验室研究相关产品：
Albuwell M：用于检测小鼠样本中的微白蛋白尿。
Nephrat II：用于检测大鼠样本中的微白蛋白尿。
Glyco-Albumin R：用于检测大鼠血清中的糖化白蛋白等。
（4）糖尿病及其并发症研究相关的试剂及标准参照品：
A717：抗糖化白蛋白单克隆抗体。
E85：抗糖化血红素的单克隆抗体。
ES12：抗糖化LDL的单克隆抗体等。
艾美捷科技代理USP标准品。
U.S. Pharmacopeia (USP)是一个独立的科学非营利组织，致力于建立优质标准品供应。
USP 一直致力于确保人们可以信赖的安全、优质药品的强大、持续供应。通过其标准、科学专业知识和能力建设解决方案，USP 能够利用由监管机构、行业领导者和制造商组成的全球网络来实现更具弹性的药品供应链。USP 的产品和解决方案包括 USP 参考样品、复合药典、膳食补充剂验证、教育课程和其他资源。范围涵盖：
<生物制剂
抗生素
碳水化合物
细胞、基因与组织
关键试剂
肝素
微生物学
单克隆抗体
寡核苷酸
肽
蛋白质
原材料
疫苗
生物制剂-培训课程
即将推出
可提取物和浸出物（E&L）
膳食补充剂和草药
氨基酸
植物药-草药
矿物质
其他-膳食补充剂
维生素
膳食补充剂和草药-培训课程
即将推出
辅料
赋形剂
黏合剂与填充剂
缓冲剂与pH调节剂
螯合剂
包衣材料
稀释剂
崩解剂
双活性成分
润肤剂与软膏基质
调味剂与着色剂
助流剂与润滑剂
杂质
乳酸-乙交酯（LG）聚合物
防腐剂
溶剂
表面活性剂
赋形剂-培训课程
食品相关
掺假物
氨基酸
碳水化合物
色素
脂肪与油脂
香精与香料
功能性成分
婴幼儿配方食品成分
基质材料
防腐剂
蛋白质与氨基酸
甜味剂
食品-培训课程
FCC分析材料
小分子
杂质
系统适用性
培训课程
即将推出
可提取物和浸出物（E&L）
相关药物物质
其他
测定（Assay）
溶出度（Dissolution）
元素杂质（Elemental Impurities）
熔点（Melting Point）
其他-通则（Others-General Chapters）
性能标准（Performance Standards）
塑料（Plastics）
残留溶剂（Residual Solvents）
系统适用性（System Suitability）
培训课程（Training Courses）
可提取物和浸出物（Extractables and Leachables，E&L）
< " data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理USP标准品"> 艾美捷科技代理USP标准品艾美捷科技代理USP标准品。
U.S. Pharmacopeia (USP)是一个独立的科学非营利组织，致力于建立优质标准品供应。
USP 一直致力于确保人们可以信赖的安全、优质药品的强大、持续供应。通过其标准、科学专业知识和能力建设解决方案，USP 能够利用由监管机构、行业领导者和制造商组成的全球网络来实现更具弹性的药品供应链。USP 的产品和解决方案包括 USP 参考样品、复合药典、膳食补充剂验证、教育课程和其他资源。范围涵盖：
<生物制剂
抗生素
碳水化合物
细胞、基因与组织
关键试剂
肝素
微生物学
单克隆抗体
寡核苷酸
肽
蛋白质
原材料
疫苗
生物制剂-培训课程
即将推出
可提取物和浸出物（E&L）
膳食补充剂和草药
氨基酸
植物药-草药
矿物质
其他-膳食补充剂
维生素
膳食补充剂和草药-培训课程
即将推出
辅料
赋形剂
黏合剂与填充剂
缓冲剂与pH调节剂
螯合剂
包衣材料
稀释剂
崩解剂
双活性成分
润肤剂与软膏基质
调味剂与着色剂
助流剂与润滑剂
杂质
乳酸-乙交酯（LG）聚合物
防腐剂
溶剂
表面活性剂
赋形剂-培训课程
食品相关
掺假物
氨基酸
碳水化合物
色素
脂肪与油脂
香精与香料
功能性成分
婴幼儿配方食品成分
基质材料
防腐剂
蛋白质与氨基酸
甜味剂
食品-培训课程
FCC分析材料
小分子
杂质
系统适用性
培训课程
即将推出
可提取物和浸出物（E&L）
相关药物物质
其他
测定（Assay）
溶出度（Dissolution）
元素杂质（Elemental Impurities）
熔点（Melting Point）
其他-通则（Others-General Chapters）
性能标准（Performance Standards）
塑料（Plastics）
残留溶剂（Residual Solvents）
系统适用性（System Suitability）
培训课程（Training Courses）
可提取物和浸出物（Extractables and Leachables，E&L）
< " data-original="http://panagene.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理USP标准品"> 艾美捷科技代理USP标准品地址：武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话：15172431432
传真：18327026838
邮箱：sales@amyjet.com
0.1691
